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Abstract 
Protein degradation mediated by the 26S proteasome is fundamental for cell survival in 
eukaryotes. There are two known routes for substrate presentation to the 26S proteasome- 
the ubiquitin-dependent route and the ubiquitin-independent route. Ornithine decarboxylase 
(ODC) is one of the most well-known ubiquitin-independent substrates of the proteasome. It 
is a homodimeric protein functioning as a rate-limiting enzyme in polyamine biosynthesis. 
Polyamines regulate ODC levels by a feedback mechanism mediated by the ODC regulator 
called antizyme. Higher cellular polyamine levels promote translation of antizyme mRNA and 
inhibit ubiquitin-dependent proteasomal degradation of the antizyme protein. Antizyme binds 
ODC monomers and targets them to the proteasome without ubiquitylation. The mechanism 
of this ubiquitin-independent proteasomal degradation is poorly understood. Therefore, the 
major aim of this study was to investigate the mechanism of ubiquitin-independent 
degradation of the ODC by the 26S proteasome. We show that polyamines, besides their 
role in regulating antizyme synthesis and stability, directly enhance antizyme-mediated ODC 
degradation by the 26S proteasome. Polyamines specifically enhanced the degradation of 
ODC by the proteasome both in vivo in yeast cells and in a reconstituted in vitro system. 
ODC is shown to be targeted in a manner quite distinct from ubiquitin-dependent substrates 
as its degradation was enhanced in a mutant lacking multiple ubiquitin receptors. These and 
other findings indicate, however, that there is a convergence point for the two routes of 
degradation because ubiquitin-dependent substrates compete with ODC for degradation. 
Using an in vitro assay, it could be shown that the unstructured N-terminal degron, ODS, is 
essential for binding of ODC to the proteasome. In vivo studies using proteasomal ATPase 
mutants, in which tyrosine residues in so-called pore loops were mutated to alanine (Y-A), 
further showed that the pore loops of Rpt4 and Rpt5 are of critical importance for ODC 
degradation and suggested that ODS might be recognized by these ATPase subunits. 
Additional experiments revealed that antizyme promotes ODC degradation most likely by 
providing an additional binding site. An ODS-antizyme-Ura3 fusion protein was degraded 
faster in a ubiquitin-independent but proteasome-dependent manner than ODS-Ura3. 
Furthermore, a ubiquitin-dependent mode of ODC degradation is also reported. Upon 
overexpression under the PCUP1 promoter, efficient degradation of ODC involved a ubiquitin-
dependent mechanism. This degradation of ODC was independent of ODS and antizyme. 
Together, the findings described in this thesis provide novel insights into the mechanism of 
proteolytic regulation of ODC. With ODC being a validated target for cancer therapy, a 
detailed understanding of this mechanism may contribute to the discovery of new therapies 
targeting the polyamine pathway.  
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Zusammenfassung 
Proteinabbau durch das 26S-Proteasom ist von fundamentaler Bedeutung für das Überleben 
eukaryotischer Zellen. Substrate können dem Proteasom auf zwei Arten präsentiert warden, 
entweder Ubiquitin-abhängig oder Ubiquitin-unabhängig. Ornithine decarboxylase (ODC) ist 
das bekannteste  Ubiquitin-unabhängige Substrat des Proteasoms. Es ist ein homodimeres 
Protein mit einer geschwindigkeitsbestimmenden Funktion in der Biosynthese von 
Polyaminen. Polyamine regulieren die ODC-Konzentration durch einen Feedback-
Mechanismus, der durch das ODC-Regulatorprotein Antizym vermittelt wird.  Höhere 
zelluläre Polyamin-Konzentrationen stimulieren die Translation von Antizym-mRNA und 
hemmen den Ubiquitin-abhängigen Abbau des Antizym-Proteins. Antizym bindet an ODC-
Monomere und vermittelt deren Ubiquitin-unabhängigen Abbau durch das Proteasom. Der 
Mechanismus des Ubiquitin-unabhängigen Proteinabbaus durch das Proteasom ist noch 
nicht gut verstanden. Das Hauptziel dieser Arbeit war es daher, den Mechanismus des 
Abbaus der ODC näher zu untersuchen. Es konnte gezeigt warden, dass Polyamine, neben 
ihrer Rolle in der Regulation der Synthese und Stabilität von Antizyme, einen direkt 
verstärkenden Effekt auf den Antizym-vermittelten Abbau der ODC durch das 26S-
Proteasom sowohl in vivo in Hefezellen als auch in einem rekonstituierten In vitro-System 
hat. ODC wird auf eine andere Art und Weise vom Proteasom erkannt als Ubiquitin-
abhängige Substratproteine, wie der verstärkte Abbau der ODC in Hefemutanten mit 
fehlenden Ubiquitin-Rezeptoren zeigte. Diese und andere Ergebnisse deuteten an, dass 
ODC und Ubiquitin-abhängige Substrate aber auch an einem  bestimmten Punkt 
zusammenkommen, da diese Substrate um den Abbau durch das Proteasom konkurrieren. 
Durch In vitro-Bindungsstudien konnte gezeigt werden, dass das unstrukturierte N-terminale 
Abbaussignal (ODS) für die Bindung der ODC an das Proteasom essentiell ist. In vivo-
Experimente mit Hefemutanten, in denen kritische Tyrosinreste in den so genannten Pore 
Loops der ATPase-Untereinheiten zu Alanin mutiert sind, zeigten das diese Loops der 
Untereinheiten Rpt4 und Rpt5 für den Abbau der ODC von kritischer Bedeutung sind, 
vermutlich indem sie das ODS erkennen. Weitere Experimente erbrachten Hinweise darauf, 
dass Antizym wahrscheinlich den Abbau der ODC fördert, indem es eine zusätzliche 
Bindestelle für das Proteasom beisteuert. So wurde beobachtet, dass ein ODS-Antizym-
Ura3-Fusionsprotein schneller Ubiquitin-unabhängig abgebaut wurde als ODS-Ura3. Neben 
dem zuvor genannten Mechanismus wurde auch ein Ubiquitin-vermittelter Abbau der ODC 
beobachtet, wenn diese in stärkerem Maße in den Zellen synthetisiert wurde. Dieser Abbau 
erwies sich als unabhängig von ODS und Antizym. Die Ergebnisse dieser Arbeit eröffnene 
neue Einblicke in die Mechanismen der proteolytischen Kontrolle der ODC.  Da ODC bereits 
als Zielstruktur von Krebstherapien validiert ist, kann ein detaillierteres Verständnis dieser 
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regulatorischen  Mechanismen zur Entwicklung neuer Therapien beitragen, die einer häufig 
mit der Zellentartung einhergehenden Erhöhung der Polyaminsynthese entgegen wirken.   
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1. Introduction 
1.1. Proteolysis in eukaryotes 
About 70 years ago, it was widely accepted that proteins were stable constituents in 
living cells (Ciechanover, 2012). After years of pioneering research we now know that 
protein degradation plays a pivotal role in the maintenance of all cells. Abnormal and 
unwanted proteins are timely eliminated by the cellular machinery. Proteins are 
broken down into its constituent amino acids which are then utilized for new protein 
synthesis. Proteolysis in eukaryotes is carried out via two known systems– lysosome-
dependent macroautophagy (autophagy) and ubiquitin-proteasome system (UPS). 
Lysosomes are organelles that contain an array of enzymes which degrade proteins 
as well as cellular organelles through the mechanism of autophagy. Alternatively, 
proteasomal degradation of proteins is achieved by conjugation of target proteins 
with a post-translational polyubiquitin modification and their subsequent degradation 
by a barrel shaped complex called the 26S proteasome (Lilienbaum, 2013). Until 
recently, the two mechanisms were thought to be independent of each other. 
However, recent studies suggest a cross-talk between them. Impairment of UPS has 
been shown to induce autophagy (Pandey et al., 2007) and the inhibition of 
autophagy led to an induction of proteasome activity by up-regulation of proteasomal 
subunits (Wang et al., 2013). The principles of proteasome-mediated degradation are 
described in sections below.  
1.1.1. The 26S proteasome 
During the late 70s, Hershko, Ciechanover and Rose characterized a non-lysosomal 
energy requiring proteolytic system now known as the ubiquitin-proteasome system 
(Ciechanover, 2012). A decade later, Hough et al. partially purified the protease 
responsible for such an ATP-dependent degradation of ubiquitin-conjugated proteins 
which later came to be known as the 26S proteasome (Hough et al., 1986).  Since 
then, decades of intensive research have increased our understanding of the 
structure and function of the proteasome. The proteasome is now a validated target 
for cancer therapies (Almond and Cohen, 2002). In May 2003, Bortezomib, a 
proteasome inhibitor was approved by the US FDA as a treatment for multiple 
myeloma.   
The 26S proteasome is a ~2.5 MDa multi-subunit degradation machinery which 
selectively degrades 80-90% of cellular proteins (Lilienbaum, 2013). It consists of two 
major subcomplexes, the 20S core particle (20S or CP) and the 19S regulatory 
particle (19S or RP) (Fig. 1A). The crystal structure of the yeast 20S proteasome 
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revealed that it is composed of four stacked heptametrical rings arranged as an (α1- 
α7, β1- β7)2 complex. The α-ring consists of seven subunits which are predominantly 
structural components of the 20S whereas the β-ring houses the catalytic domains of 
the proteasome. Out of the seven subunits of the β-ring, the β1, β2 and β5 subunits 
harbor the proteolytic active sites (Tomko and Hochstrasser, 2013).  
 
 
Fig.1: Structure of the 26S proteasome. (A) Surface representation of the 26S proteasome 
structure with the 20S core particle capped on both sides by the 19S regulatory particles (RP). (B) 
Surface representation of the 19S RP structure showing the relative positions of the subunits of the lid 
and base subcomplexes. (C) Surface representation of the lid subcomplex. (D) Surface 
representation of the base subcomplex. All structural representations were obtained using the PDB 
structures 4CR and 1RYP and viewed using the 3D molecular visualization software PyMOL
TM
.   
The 19S RP (Fig. 1B) caps the CP, thereby regulating substrate entry into the CP. It 
does so by harbouring receptors for ubiquitin binding, detaching ubiquitin tags, 
opening the 20S CP gate, as well as by unfolding and translocating the substrate into 
the CP. Under certain in vitro conditions, the RP was shown to dissociate into two 
subcomplexes, the base and the lid (Michael H. Glickman, 1999). The base consists 
of a heterohexameric AAA+ ATPase ring (consisting of the subunits, Rpt1-Rpt6) and 
three non-ATPase subunits, namely Rpn1, Rpn2 and Rpn13 (Fig. 1B and 1D). The 
major functions of the base are 20S gate opening and substrate unfolding and 
19S
19S
20S
26S proteasome
19S
Lid
Base
Rpn13
Rpn1
Rpn2
Rpn11
Rpt ring
A B C
D
Rpn3, 5-9, 12, 
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Rpn10
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translocation into the 20S. The unfolded substrates are then threaded through the 
narrow 20S pore by using the chemical energy from ATP hydrolysis. The Rpn1 and 2 
are the largest subunits of the proteasome. Rpn1 serves as the docking sites of 
extrinsic ubiquitin receptors such as Rad23, Dsk2 and Ddi1. Rpn1 and 2 are 
hypothesised to serve as a loading platform for incoming substrates. Apart from 
these, the Rpn13 functions as a ubiquitin receptor. The RP lid consists of 9 Rpn 
subunits-Rpn3, 5-9, 11, 12 and Sem1 (Fig. 1B and 1C). The lid is essential for the 
degradation of ubiquitylated substrates. Rpn11 functions as the deubiquitylating 
enzyme (DUB).  Rpn10 is an intrinsic ubiquitin receptor (Forster et al., 2009; Nickell 
et al., 2009; Tomko and Hochstrasser, 2013; Walz et al., 1998).  
It took more than a decade after the solving of the crystal structure of the 20S CP to 
resolve the structure of the 19S RP. An atomic structure of the latter by 
crystallography could not be achieved mainly because of its dynamic nature.  In 
2012, two laboratories independently published subnanometer CryoEM structures of 
the yeast 19S RP (Beck et al., 2012; Lander et al., 2012). This was achieved using 
various techniques combined with CryoEM, including a novel approach for 
heterologous co-expression in E.coli, antibody and GST-fusion labelling and the use 
of deletion mutants. Interestingly, the lid subcomplex was found to be attached to the 
side of the 19S RP, which contrasted with previous ideas (Fig. 1B and 1C). The Rpt 
subunits of the base (marked as Rpt ring in Fig. 1B) were shown to be arranged in a 
spiral staircase, and the pore of the Rpt ring does not align with the pore of the 20S. 
The ubiquitin receptors, Rpn10 and Rpn13, are flexibly attached to the periphery of 
the RP. The Rpn11 deubiquitylase subunit is positioned directly above the entrance 
of the pore of the Rpt ring. Rpn1 is very closely associated with the ATPase ring, 
whereas Rpn2 is placed distally along the long axis of the proteasome and a part of it 
is positioned above the pore of the Rpt ring (Fig. 1B and 1D).  
In a recent review, Inobe and Matouschek have described three different modes of 
substrate recognition by the proteasome: (1) ubiquitin-dependent, (2) adaptor-
mediated, and (3) ubiquitin-independent. The first two modes depend on ubiquitin-
tagging of the substrate for proteasome recognition whereas the third one is 
independent of ubiquitin-tagging. In all three modes of proteasome recognition, a 
common principle is the engagement of an unstructured domain in the substrate by 
the ATPase ring to initiate degradation (Inobe and Matouschek, 2014). The modes of 
proteasomal targeting are detailed in the subsections below.   
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1.1.2. Ubiquitin-dependent proteasomal targeting 
There are a growing number of proteins whose cellular function is regulated by their 
timely elimination by the ubiquitin-proteasome system (UPS). The UPS is known to 
be involved in many vital cellular processes ranging from DNA repair, cell cycle 
regulation, and cell migration to immune responses (Melvin et al., 2013). On the 
clinical side, therapies targeting the UPS are underway for several diseases. Two 
drugs, Bortezomib and Carfilzomib, both proteasome inhibitors, are already in the 
clinic as a treatment for multiple myeloma (Melvin et al., 2013). It is therefore critical 
to further understand the details of the mechanisms of protein degradation by the 
UPS. 
The ubiquitin-dependent substrate targeting and recognition is the more extensively 
studied route of proteasome targeting. It involves a series of enzymatic reactions 
wherein ubiquitin, a 8.5 KDa protein modifier, is conjugated to a target protein as 
detailed in Fig. 2. In Saccharomyces cerevisiae, there is only one known E1 enzyme 
encoded by UBA1, 11 known E2s and 42 different E3s. (Lee et al., 2008; McGrath et 
al., 1991). In most cases, ubiquitin conjugation takes place via a peptide bond formed 
between the Gly76 of ubiquitin and a lysine residue in the substrate. Polyubiquitin 
chains are formed by attaching another ubiquitin to a lysine residue (e.g. Lys48) of 
the preceding ubiquitin (Glickman and Ciechanover, 2002). This process is reversible 
as cells also contain deubiquitylating enzymes (DUBs) which remove the ubiquitin 
chains from substrates (Komander et al., 2009).  
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Fig. 2: The ubiquitin-proteasome system. Shown are the steps involved in the ubiquitin-dependent 
degradation of a target protein. Individual ubiquitin moieties are activated in an ATP dependent 
manner by the E1 ubiquitin-activating enzyme. The ubiquitin is then transferred to an E2, ubiquitin- 
conjugating enzyme. Subsequently, the activated ubiquitin-loaded E2 interacts with a specific E3, 
which are protein ligases directly in contact with a substrate. Ubiquitin is then covalently attached to 
one or more lysines within the target protein. Polyubiquitylation is achieved by attaching additional 
ubiquitins to the initial ubiquitin via one of its seven lysines. The polyubiquitylated substrate is then 
recognised by the shuttle factors or intrinsic ubiquitin receptors in the 19S RP. The ubiquitin chain is 
cleaved off from the substrate by the deubiquitylase, Rpn11 and recycled. The substrate is unfolded 
by the Rpt1-6 ATPases and translocated into the CP for degradation. 
Recently, a more detailed understanding of the ubiquitin-dependent substrate 
targeting to the proteasome has emerged. The various steps involved in this process 
are detailed in Fig. 3. Apart from the ubiquitin tag, an unstructured region in the 
substrate is required for efficient proteasomal degradation (Prakash et al., 2004). 
Recent CryoEM structure of an actively translocating 26S proteasome shows that 
this unstructured initiation region makes contact with the N-ring (the ring formed by 
the N-terminal domains of the ATPases) once the substrate is tethered to the 
proteasome via a ubiquitin receptor.  Furthermore, the active site of the Rpn11 
deubiquitylase is masked to prevent premature deubiquitylation. Upon substrate 
E1
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E3
Polyubiquitin
Ubiquitin
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engagement by the Rpt ring, the proteasome undergoes structural changes. As a 
result, a continuous central channel to the 20S core is formed for substrate 
degradation. The Rpn11 active site is unmasked as it shifts to a position directly 
above the N-ring thereby scanning and removing ubiquitin chains from the 
translocating polypeptide.  
 
Fig. 3: Proteasomal degradation of a ubiquitylated substrate. Upon substrate recognition through 
polyubiquitin binding to the receptors Rpn13 and Rpn10, the Rpt ring of the proteasome initiates 
degradation at an unstructured region in the substrate. Structural rearrangements upon successful 
engagement lead to unfolding and translocation of the substrate to the 20S CP as well as cleavage of 
the ubiquitin tag. The substrate is completely unfolded and cleaved into peptides. Adapted from 
(Bhattacharyya et al., 2014).  
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1.1.3. Ubiquitin-independent proteasomal targeting 
Most of the known proteasomal substrates require ubiquitylation for their 
degradation. However, there are a significant number of proteins the degradation of 
which does not require ubiquitin conjugation. This mode of degradation is 
hypothesised to be a remnant of the ubiquitin-free degradation observed in the 
archaea and bacteria (Erales and Coffino, 2013; Inobe and Matouschek, 2014). Such 
substrates are characterized by observing their proteasomal degradation when 
ubiquitylation is impaired either by inactivating the ubiquitin-activating enzymes or by 
mutating all receptor lysines on the protein (Jariel-Encontre et al., 2008). The 
mechanism of such a ubiquitin-independent proteasomal targeting still remains 
unclear. However, it has been speculated that presence of an unstructured domain in 
these proteins is sufficient for proteasome association (Inobe and Matouschek, 
2014). Based on biochemical analyses of mammalian lysates, Baugh et al. have 
reported that more than 20% of cellular proteins are regulated by degradation in an 
ubiquitin-independent manner by both the 20S and 26S proteasomal species (Baugh 
et al., 2009). Using in vitro experiments, it was shown that oxidatively damaged 
proteins can be degraded by the 20S proteasome, independent of ubiquitin (Davies, 
2001). Ornithine decarboxylase (ODC), Rpn4 and thymidylate synthase are 
examples of ubiquitin-independent substrates, degradation of which is strictly ATP-
dependent and therefore requires the 26S proteasome (Erales and Coffino, 2013). 
Taken together, these observations bring us to two different modes of ubiquitin-
independent proteasomal degradation, one that is ATP-dependent mediated solely 
by the 26S proteasome and another ATP-independent one mediated mainly by the 
20S proteasome. This thesis deals with the former mode of ubiquitin-independent 
proteasomal degradation in particular with the ubiquitin-independent degradation of 
ornithine decarboxylase (ODC) in yeast.  
ODC is the best-studied ubiquitin-independent substrate. It is conserved from yeast 
to humans (Palanimurugan et al., 2014). In 1989, Bercovich et al. observed that the 
degradation of ODC occurs in a ubiquitin-independent but ATP-dependent manner in 
reticulocyte lysates (Bercovich et al., 1989) which was later shown to occur in vivo in 
mammalian cells as well (Rosenberghasson et al., 1989). Since then several 
laboratories have tried to further understand this mechanism of ubiquitin-independent 
degradation of ODC. However, this mechanism is still not fully understand and is 
therefore a major focus of this thesis.  
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1.2.  Feedback regulation of polyamines in eukaryotes 
ODC is the rate-limiting enzyme in the biosynthesis of a class of molecules called 
polyamines. The current understanding of the feedback regulation of polyamines 
involving ODC and other players is described in subsections below. 
1.2.1. Polyamine types and their biosynthesis 
Polyamines are ubiquitous polycations essential for cell survival. Polyamines play 
multiple roles in the cell and are involved in almost all cellular processes. These 
include DNA replication, apoptosis, transcription, translation and membrane stability 
(Palanimurugan et al., 2014). Spermidine and spermine derived from the diamine 
precursor putrescine are the major polyamines in the cell (Fig. 4). Spermidine is 
formed from putrescine and spermine from spermidine by the addition of an 
aminopropyl group (Wallace, 2009).  
                             
Fig. 4: Polyamine types and their structure. 
Biosynthesis of polyamines in S. cerevisiae is outlined in Fig. 5. The polyamine 
biosynthetic pathway and it regulation is highly conserved from yeast to humans. 
Therefore, S. cerevisiae serves as a useful model organism to delve deeper into the 
regulatory mechanisms of this pathway.  
Polyamines are regulated not only at the level of their biosynthesis but also at their 
catabolism and transport. Acetylated polyamines are either exported from the cell or 
subjected to oxidation by polyamine oxidase (Fms1 in yeast; shown in Fig. 5). In 
mammals, oxidation of N-acetylspermine and N-acetylspermidine produces 
spermidine or putrescine respectively, along with 3-aceto-aminopropanal and 
hydrogen peroxide (H2O2) (Palanimurugan et al., 2014). In mammals, the 
spermidine/spermine N1-acetyltransferase (SSAT) is a well-characterized enzyme in 
polyamine catabolism (Casero and Pegg, 1993). Liu et al. have recently 
Putrescine
Spermidine
Spermine
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characterized a yeast gene that encodes a polyamine acetyltransferase called Paa1. 
All polyamine types were shown to be acetylated by Paa1 in vitro (Liu et al., 2005).  
The polyamine biosynthetic pathway is an established chemopreventive and 
chemotherapeutic target (Nowotarski et al., 2013). The major reasons as 
summarized by Wallace are (1) polyamines are essential for cell growth (2) elevated 
polyamine levels are observed in cancer cells (3) ODC is designated as an oncogene 
as its levels are also elevated in cancer cells (4) inhibition of polyamine biosynthesis 
inhibits cell growth (Wallace, 2009).  
Numerous tumour types have been associated with altered polyamine levels. These 
include breast, colon, prostrate and skin cancers. The ODC inhibitor 2-
difluoromethylornithine (DFMO)/eflornithine was once a promising candidate for 
chemotherapy although later the clinical trials did not validate its effectiveness 
(Nowotarski et al., 2013). However in recent clinical trials, DFMO showed promise as 
a chemopreventive agent. For example, recent phase II clinical trials for prostate 
cancer have shown that the ODC inhibitor difluoromethylornithine (DFMO) reduced 
prostate polyamine levels in patients at risk for invasive prostate cancer (Meyskens 
et al., 2014).  AdoMetDC and polyamine oxidases are also potential targets for 
therapy. Methylglyoxal bis(guanylhydrazone) (MGBG) and 4-Amidoinoindan-1-one-
2’-amidinhydrazone (SAM486A) are inhibitors of AdoMetDC. N,N1-Bis(2,3-
butadienyl)-1,4-butanediamine (MDL 72527) is an inhibitor of polyamine oxidases 
(Nowotarski et al., 2013). An alternative approach for inhibiting the polyamine 
pathway is by using polyamine analogues (Porter and Bergeron, 1988). Polyamine 
analogues like BENSpm can be easily taken in by the cell using the polyamine 
transport pathway thereby inhibiting polyamine biosynthesis and increasing 
polyamine catabolism. For example BENSpm downregulates ODC and AdoMetDC 
while inducing SSAT and SMO (spermine oxidase) (Nowotarski et al., 2013).  
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Fig. 5: Biosynthesis of polyamines in yeast. Ornithine, the precursor for polyamine biosynthesis is 
decarboxylated to the diamine putrescine by Spe1/ODC (Ornithine decarboxylase). Putrescine is then 
converted to the triamine spermidine by Spe3 (Spermidine synthase) and subsequently to the 
tetraamine spermine by Spe4 (Spermine synthase). The aminopropyl moieties for spermidine and 
spermine synthesis come from decarboxylated S-adenosylmethionine (dc-SAM) upon decarboxylation 
of s-adenosylmethionine (SAM) by Spe2 (SAM decarboxylase). Spermine can be converted back to 
spermidine by Fms1 (Polyamine oxidase). The polyamines can be converted to several acetylated 
forms by the enzyme Paa1 (Polyamine acetyltransferase). Adapted from (Rato et al., 2011).   
1.2.2.  Regulation of ODC by antizyme 
Due to their myriad roles in the cell, polyamines are subjected to tight regulation. 
Polyamines regulate their biosynthetic enzymes through feedback control. This is 
mainly accomplished by controlling ODC levels in the cell (Igarashi and Kashiwagi, 
2010).  In mammals, ODC levels are regulated at the level of transcription, translation 
as well as degradation. Odc gene promoter contains elements responsive to 
hormones and growth factors. ODC is also a target of the oncogene c-myc. ODC 
mRNA has a long 5´-untranslated region (UTR) which contributes to its translational 
regulation. High leveIs of the translation initiation factor, eIF-4E, therefore enhances 
the translation of ODC mRNA, which is suggested to be involved in malignant 
transformation. The ODC 5´-UTR also contains an upstream open reading frame 
(uORF) that has been shown to regulate ODC translation in vitro (Pegg, 2006; Perez-
Leal and Merali, 2012).  
ODC is one of the most short-lived enzymes in eukaryotic cells with a half-life 
estimated between 10 and 60 min in mammals (Persson, 2009). This rapid turnover 
is mediated by the 26S proteasome in a ubiquitin-independent manner. Fig. 6 depicts 
Fms1
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an overview of the post-translational regulation of ODC by polyamines. ODC 
degradation is regulated through the synthesis of a regulatory protein called ODC 
antizyme (Kahana, 2009). In mammals four different ODC inhibiting antizyme 
isoforms are known. Among these, the most predominant is antizyme-1 which has a 
wide tissue distribution. Though expressed at lower levels, antizyme-2 is similar to 
antizyme-1 and promotes ODC degradation in vivo. Antizyme-3 is a testis specific 
protein, which is restricted to a late stage in spermatogenesis. It however does not 
target ODC for degradation. There is also an antizyme-4 but it is not very well 
characterized (Olsen and Zetter, 2011).  In yeast, however, only one isoform is 
known that is encoded by OAZ1 (Palanimurugan et al., 2004). Antizyme levels are 
also strictly regulated by cellular polyamines. It occurs at the level of translation of 
antizyme mRNA as well as at its degradation, which is inhibited in response to 
increased cellular polyamine levels (Palanimurugan et al., 2004). The translational 
control of antizyme takes place via a conserved mechanism of +1 ribosomal 
frameshifting (Matsufuji et al., 1995; Palanimurugan et al., 2004). Antizyme mRNA is 
unique as it has a stop codon in its reading frame. For synthesis of full length protein, 
the ribosome has to skip the inner stop codon and continue till it reaches the stop 
codon at the end of the mRNA. This process is regulated by cellular polyamine 
levels, the mechanism for which remained elusive for a long time. Recent studies 
from our laboratory have shown that polyamine binding to a PRE (polyamine 
responsive element) on the nascent antizyme polypeptide is the key that regulates 
antizyme translation.  At low cellular polyamine concentrations, ribosomes that 
undergo +1 ribosomal frameshifting within a polysome on antizyme mRNA, stall 
close to the end of the coding sequence thereby preventing completion of translation. 
When polyamine levels rise, the binding of polyamines to the PRE deregulates the 
inhibition resulting in the release of full length antizyme polypeptide. Although this 
study was carried out in yeast, there is an indication that this is a conserved 
phenomenon as they also showed that polyamines bind human antizyme in vitro 
(Kurian et al., 2011). The second level of antizyme regulation is by its ubiquitin-
dependent proteasomal degradation. High polyamine levels stabilize antizyme by 
preventing its degradation, the mechanism of which is not yet fully understood 
(Palanimurugan et al., 2004).  
In mammals, antizyme is also regulated by a ODC-like protein called antizyme 
inhibitor. Unlike ODC, under physiological conditions antizyme inhibitor is a monomer 
and therefore binds antizyme with an affinity greater than ODC. This interaction 
inactivates antizyme thereby resulting in higher cellular polyamine concentrations by 
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synthesis and uptake.  Antizyme inhibitor is rapidly degraded in a ubiquitin-
independent manner. To date, two different isoforms of antizyme inhibitor are known 
-antizyme inhibitor-1 and antizyme inhibitor-2 (Kahana, 2009; Olsen and Zetter, 
2011).  
 
Fig. 6: Feedback regulation of polyamines in yeast. Shown here is an overview of the feedback 
regulation of cellular polyamines via ODC and antizyme. Following high cellular polyamine levels, 
antizyme synthesis is augmented via a unique +1 ribosomal frameshifting of antizyme mRNA. 
Antizyme forms heterodimers with ODC monomers resulting in the exposition of an N-terminal 
unstructured domain in ODC termed ODS (ODC degradation signal). ODC is subsequently targeted 
to the 26S proteasome in a ubiquitin-independent manner whereas the antizyme is recycled. 
Moreover, antizyme levels are controlled posttranslationally by its ubiquitiylation followed by 
proteasomal degradation. Polyamines inhibit this ubiquitin-dependent degradation of antizyme.  
1.2.3. ODC degradation: the story so far 
ODC is a 52 KDa protein functional only in its homodimeric form. The ODC monomer 
exists in equilibrium with the homodimer (Coleman et al., 1994). Antizyme binds to 
ODC monomers and facilitates their ubiquitin-independent degradation by the 26S 
proteasome. A 37 amino acid C-terminal region of mouse ODC (termed cODC) was 
found to be essential for its degradation.  cODC was later confirmed as the degron by 
sequence comparison of mODC with ODC from Trypanosoma brucei (TbODC) which 
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lacks cODC and is therefore a stable protein in mammalian cells. cODC functioned 
as a transplantable degron as it mediated ubiquitin-independent degradation of 
TbODC once transplanted. Antizyme is not essential for the turnover of mODC but it 
greatly enhances it. Antizyme binding is thought to expose the cODC which is 
otherwise buried in the ODC homodimer. However, it remains unclear whether 
antizyme plays a further role in mODC degradation (Erales and Coffino, 2013). In S. 
cerevisiae, however, antizyme is essential for the degradation of ODC 
(Palanimurugan et al., 2004).  The yODC (yeast ODC) degron is a ~45 residue N-
terminal unstructured domain called ODC Degradation Signal (ODS) which is 
exposed upon antizyme binding. This degron is both transplantable and replaceable. 
However, the transplantable nature of the degron depends on the structural context 
of the receptor protein. An alpha helical domain succeeding the unstructured domain 
was found to be a contributing factor in degradation (Godderz et al., 2011; Li and 
Coffino, 1993). 
1.3. Other ubiquitin-independent substrates 
There are only a handful of well-characterized ubiquitin-independent substrates. 
Apart from ODC, yeast Rpn4, a transcriptional regulator of proteasome genes, and 
mammalian thymidylate synthase (TS), an enzyme involved in the synthesis of DNA 
precursors are the other known substrates. Presence of an unstructured domain 
containing degron is the common feature among these substrates (Erales and 
Coffino, 2013). Rpn4 distinguishes itself from the other two as it is degraded via the 
ubiquitin-dependent as well as ubiquitin-independent modes (Ju and Xie, 2004). Like 
yeast ODC, the ubiquitin-independent degron of Rpn4 is at its N-terminus consisting 
of the first 80 residues. Recently, Ha et al. have reported that the N-terminal degron 
of Rpn4 interacts with the proteasomal subunits Rpn2, Rpn5 and Rpt1 by using a 
cross-linking label transfer technique (Ha et al., 2012). On the other hand, in vivo 
data from our laboratory showed that the proteasome lid is dispensable for ODC 
degradation (Godderz et al., 2011). Therefore, the mode of proteasomal reception of 
ubiquitin-independent substrates still remains to be elucidated. Similar to ODC and 
Rpn4, the degron of TS consists of an N-terminal unstructured domain spanning 
residues 1-28. Besides this degron, the presence of an N-terminal proline and the 
residues 9-15 was also critical for TS degradation. Another common feature with 
ODC was the α-helix following the degron which contributed to the efficiency of 
degradation (Pena et al., 2009). 
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Apart from these, there are substrates that are ubiquitylated but also degraded in a 
ubiquitin-independent manner. The mode of their degradation is still under debate. 
These comprise p21/Cip1, the TCRα subunit of the T cell receptor, IκBα, c-Jun and 
calmodulin (Hoyt and Coffino, 2004). p21 is a loosely folded protein that is 
ubiquitylated in vivo. However, a lysine-less variant of p21 is still unstable showing 
that its degradation does not completely rely on ubiquitylation (Sheaff et al., 2000). 
Later, p21 was shown to be polyubiquitylated at the free amino group of its N-
terminal methionine which was shown to be sufficient for its degradation (Bloom et 
al., 2003). Therefore, the exact mode of degradation of p21 in mammalian cells still 
remains uncertain. It is possible that both pathways might be involved.  
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2.  Aim of current study 
Recent structural studies of the 19S regulatory particle have shed light on the 
mechanistic details of ubiquitin recognition and subsequent engagement of 
substrates by the proteasome. This model was based on the relative positions of 
ubiquitin receptors, the deubiquitylase Rpn11 and the ring formed by the 6 Rpts. 
(Beck et al., 2012; Lander et al., 2012)  However, the ubiquitin-independent 
recognition of substrates is still poorly understood. This study is aimed at elucidating 
the mechanism of reception and engagement of ubiquitin-independent substrates by 
the proteasome. ODC is the primary ubiquitin-independent substrate studied in this 
thesis although other substrates such as p21 and artificial fusion proteins are also 
employed in comparative approaches. The major questions addressed in this thesis 
can be summarized as follows.  
1. Do polyamines directly influence ODC degradation? 
2. Does ODC bind the proteasome through its unstructured domain, ODS? 
3. What are the receptors in the proteasome for ODS and other unstructured 
domains? 
4. Does antizyme have a binding site on the proteasome? 
5. Is there a ubiquitin-dependent component for ODC degradation? 
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3. Materials and Methods 
3.1. Materials 
3.1.1. Saccharomyces cerevisiae strains 
Strain Genotype Lab stock Source 
JD47-
13C 
MATa his3∆200 leu2-3,112 lys2-801 trp1∆63 ura3-52 Sc. 188 
(Ramos et 
al., 1998) 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Sc. 1195 Euroscarf 
MO24 
MATa his3∆200 leu2-3,112 lys2-801 trp1∆63 ura3-52 
pre1::PRE1-FLAG-6xHIS 
Sc. 3534 
(Kock et al., 
2015) 
DG10 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 oaz1∆::Kan-MX5 Sc. 2583 Euroscarf 
spe4-∆ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 spe4∆::Kan-MX5 Sc. 1202 Euroscarf 
paa1-∆ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 paa1∆::Kan-MX5 Sc. 3188 Euroscarf 
YGA40 
MATa his3∆200 leu2-3,112 lys2-801 trp1∆63 ura3-52  
PGAL1 HSP82::Nat hsc82Δ::Kan-MX6 pdr5Δ::Hph 
Sc. 3112 
(Kandasamy, 
2014) 
YGA95 
MATα his3∆200 leu2-3,112 lys2-801 trp1∆63 ura3-52  
PGAL1-HSP82::Nat hsc82Δ::Kan-MX6, pdr5Δ::Hph rpn10-
UIM::Phe rpn13-KKD::Trp1 rad23Δ::His dsk2 Δ::Kan 
Sc. 3335 
(Kandasamy, 
2014) 
YHI29/1 MATα pre1-1 his3-11,15 leu2-3 ura3 Can
s
 Sc. 324 
Lab 
collection 
JD77-
ts26 
MATa uba1Δ::HIS3 pRSts26-1(uba1-ts-26) leu2-3,112 lys2-
801 ura3-52 
Sc. 440 
Lab 
collection 
JD59 
MATa ump1∆::HIS3 his3∆200 leu2-3,112 lys2-801 trp1∆63 
ura3-52 
Sc. 227 
(Ramos et 
al., 1998) 
YAH96 
MATα his3-∆200 leu2-3,112 lys2-801 trp1-1 ura3-52 
rpn11::RPN11-3xFLAG-HIS 
Sc. 3936 
(Erales et al., 
2012) 
JE03 
MATα his3-∆200 leu2-3,112 lys2-801 trp1-1 ura3-52 
rpn11::RPN11-3xFLAG-HIS Rpt1::rpt1 (Y283A) 
Sc. 3937 
(Erales et al., 
2012) 
MHY292 
MATα his3-∆200 leu2-3,112 lys2-801 trp1-1 ura3-52 
rpn11::RPN11-3xFLAG-HIS Rpt2::rpt2 (Y256A) 
Sc. 3938 
(Erales et al., 
2012) 
RB18 
MATα his3-∆200 leu2-3,112 lys2-801 trp1-1 ura3-52 
rpn11::RPN11-3xFLAG-HIS Rpt3::rpt3 (Y246A) 
Sc. 3968 This study 
MHY294 
MATα his3-∆200 leu2-3,112 lys2-801 trp1-1 ura3-52 
rpn11::RPN11-3xFLAG-HIS Rpt4::rpt4 (Y255A) 
Sc. 3940 
(Erales et al., 
2012) 
MHY295 
MATα his3-∆200 leu2-3,112 lys2-801 trp1-1 ura3-52 
rpn11::RPN11-3xFLAG-HIS Rpt5::rpt5 (Y255A) 
Sc. 3941 
(Erales et al., 
2012) 
RB19 
MATα his3-∆200 leu2-3,112 lys2-801 trp1-1 ura3-52 
rpn11::RPN11-3xFLAG-HIS Rpt6::rpt6 (Y222A) 
Sc. 3969 This study 
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AM33 
MATa pdr5∆::KanMX5 his3∆200 leu2-3,112 lys2-801 
trp1∆63 ura3-52 
Sc. 1954 
Lab 
collection 
RB4 
MATα his3∆200 trp1∆63 met15::Nat ura3∆::Kan 
Leu2::PODC-ODC-LEU2::Hph Can::POAZ1-OAZ1-TOAZ1 
Sc.3518 This Study 
JN54 MATa his3-11,15 leu2-3,112 lys2 trp1-∆1 ura3-52 Sc. 1032 
(Nelson et 
al., 1992) 
YMF15 MATa ssa1-45 ssa2∆::LEU2 ssa3∆::URA3 ssa4::LYS2 Sc. 1203 
(Fröhlich, 
2005) 
3.1.2. Escherichia coli strains 
Strain Genotype Source 
XL1Blue 
F
- 
φ80 lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1 
hsdR17(rk
-
, mk
+
) phoAsupE44 thi-1 gyrA96 relA1 λ
-
 
Lab 
collection 
MC1061 
hsdR2 hsdM
+
 hsdS
+
 araD139 Δ(ara-leu)7697Δ(lac)X74 galE15 
galK16 rpsL (Strr) mcrA mcrB1 
Lab 
collection 
Rosetta™ 2(DE3) 
pLysS 
F
- 
ompT hsdSB(rB
-
 mB
-
) gal dcm (DE3) pLysSRARE2 (Cam
R
) 
Lab 
collection 
BL21 codon 
F
- 
ompT gal dcm lon hsdSB(rB
- 
mB
-
) λ(DE3 [lacI lacUV5-T7gene 1 
ind1 sam7 nin5]) 
Lab 
collection 
3.1.3. Plasmids 
Name Details Lab stock Source 
YCplac33 CEN/URA3 Ec. 201 
(Gietz and Sugino, 
1988) 
YCplac111 CEN/LEU2 Ec. 202 
(Gietz and Sugino, 
1988) 
YCplac22 CEN/TRP1 Ec. 200 
(Gietz and Sugino, 
1988) 
pPM323 PCUP1-2xMyc-OAZ1-if-TCYC1, CEN/URA3 Ec. 3842 (Kurian et al., 2011) 
pDG240 pET11a-6His-OAZ1(codon optimised for E.coli) Ec. 2770 (Kurian et al., 2011) 
pDG246 
pET11a-6His-OAZ1L245A,L246A,K247A,W251A (codon 
optimised for E.coli) 
Ec. 2776 Lab collection 
pRB11 
pET11a-6His-OAZ1(codon optimised for E.coli)-
pQE-ODC-2xHa 
Ec. 3038 This study 
pRB12 
pET11a-6His-OAZ1(codon optimised for E.coli)-
pQE-ΔN47-ODC-2xHa 
Ec. 3039 This study 
pPM97 PODC-ODC-2xHa-TCYC1, CEN/LEU2 Ec. 3089 
(Godderz et al., 
2011) 
pMAF17 PCUP1-Ub-R-Ha-eK-URA3-TCYC1, CEN/LEU2 Ec. 2380 Lab collection 
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pMAF18 PCUP1-Ub-V76-Ha-eK-URA3-TCYC1, CEN/LEU2 Ec. 3665 Lab collection 
pGEX-4T-2 GST Ec. 2445 GE Healthcare 
pDG241 
pGEX4T-2-GST-OAZ1(codon optimized for 
E.coli) 
Ec. 2771 Lab collection 
pDG273 pET11a-ODC-FLAG Ec. 2803 Lab collection 
pRB24 pET11a-ODC-2xHa-6His Ec. 3339 This study 
pDG269 pCUP1-hp21-2xHa-TCYC1, CEN/URA3 Ec. 2799 Lab collection 
pDG258 PODC-ODC1-42-URA3-2xHa-TCYC1, CEN/LEU2 Ec. 2788 
(Godderz et al., 
2011) 
pDG268 PODC-URA3-2xHa-TCYC1, CEN/LEU2 Ec. 2798 
(Godderz et al., 
2011) 
pFS1 PODC-URA3-2xHa-TCYC1, CEN/LEU2 Ec. 3551 (Stadelmayer, 2014) 
pFS2 
PODC- OAZ1-if L245A,L246A,K247A,W251A URA3-2xHa-
TCYC1, CEN/LEU2 
Ec. 3552 (Stadelmayer, 2014) 
pRB40 
PODC- ODC1-47OAZ1-if L245A,L246A,K247A,W251A-TCYC1, 
CEN/LEU2 
Ec. 3553 This study 
pRB41 
PODC- ODC1-47OAZ1-if L245A,L246A,K247A,W251A- 
URA3-2xHa-TCYC1, CEN/LEU2 
Ec. 3577 This study 
pRB45 
PODC- ODC1-47OAZ1-if L245A,L246A,K247A,W251A- 
URA3-2xHa-TCYC1, CEN/TRP1 
Ec. 3649 This study 
pJDRZ1 pGAL1-Ub-R-LacZ, 2µ/HIS3 Ec. 3257 Lab collection 
pPM96 pCUP1- ODC-2xHa-TCYC1, CEN/LEU2 Ec. 3088 (Rangasamy, 2005) 
pPM106 pCUP1-ΔN47-ODC-2xHa-TCYC1, CEN/LEU2 Ec. 3096 (Rangasamy, 2005) 
pRB14 pCUP1- ODC-TCYC1, CEN/LEU2 Ec. 3193 This study 
pRB15 pCUP1-ΔN47-ODC-TCYC1, CEN/LEU2 Ec. 3194 This study 
pMAF59 PCUP1-Ub-R-e
K
-DHFR-2xHa-TCYC1, CEN/LEU2 Ec. 3451 Lab collection 
3.1.4. Oligonucleotides 
Name Sequence Description 
RB4115 
GAGGATCCATTAAAGAGGAGAAATTAACTATGTCTAGTACTC
AAGTA 
BamH1-SD (PQE)-
ODC-FP 
RB4116 
CTGGATCCTACTAGTTGAGCTCTCTAGACTGCATAGTCAGG
TACG 
Ha-stop-Sac1-Spe1-
BamH1-RP 
RB4117 
GAGGATCCATTAAAGAGGAGAAATTAACTATGAACCAAGATT
TGGAA 
BamH1-SD (PQE)-
ΔODS-ODC-FP 
RB4118 GGTTGGTGGCAAACTGAT pRB11-sequencing-FP 
RB4119 GATATAGTTCCTCCTTTCAGC pRB11-sequencing-RP 
RB4133 ACGAATTCATGTCTAGTACTCAAGTA EcoR1-ODC-FP 
RB4134 ACGAATTCATGAACCAAGATTTGGAA EcoR1-dODS-ODC-FP 
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RB4135 TTGGATCCTCAATCGAGTTCAGAGTCTAT ODC-stop-BamH1-RP 
RB4343 GACGAGCTCATCGAGTTCAGAGTCTATGT ODC-nostop-Sac1-RP 
RB4623 CGCCTCGAGGCATTCAAACTCTAAAATAACAAAG Xho1-nostop-OAZ1-RP 
RB4688 GAAGAAAAGCCTGACGTTACTTA RPT1-int-FP 
RB4689 TCAATTATATTGCATATAACGCGA RPT1-stop-RP 
RB4690 GGTTTCGGTCATGAAAATGGATA RPT2-int-FP 
RB4691 TCACAAGTATAAACCTTCTAAATT RPT2-stop-RP 
RB4692 TGACGTCACTTATGCAGATGTTG RPT3-int-FP 
RB4693 TCATTTGTAGAAGTCGAATTTATC RPT3-stop-RP 
RB4694 GTATAATATGACCAGTTTTGAAC RPT4-int-FP 
RB4695 TCATAATTTTTGGTATTCTATAGT RPT4-stop-RP 
RB4696 GAATTTGATTCTCGTGTAAAAGC RPT5-int-FP 
RB4697 TTATGCATAAAAGGATACCGATTT RPT5-stop-RP 
RB4698 GACCCACTAGTTTCGTTGATGAT RPT6-int-FP 
RB4699 TCACTTGAACAGCTTGGCGACAGA RPT6-stop-RP 
3.1.5. Enzymes  
Enzyme Supplier 
Alkaline Phosphatase NEB 
DnaseI Roche 
DreamTaq DNA Polymerase Thermo Scientific 
Lysozyme Sigma 
Phusion® High-Fidelity DNA Polymerase NEB 
Restriction Endonucleases Thermo Scientific 
T4-DNA Ligase NEB 
β-glucoronidase Roche 
3.1.6. Antibodies 
Antibody Derived from Supplier 
Anti-βeta2  Rabbit Lab collection 
Anti-Cdc11 Rabbit Santa Cruz Biotechnology 
Anti-GST Rabbit Santa Cruz Biotechnology 
Anti-HA (16B12 clone) Mouse HISS Diagnostic 
Anti-HA (3F10 clone) Rat Roche 
Anti-HSP90 Rabbit Lab collection 
Anti-FLAG (M2 clone) Mouse Sigma 
ANTI-FLAG® M2 Affinity Gel Mouse Sigma 
Anti-MYC (9B11 clone) Mouse Cell Signaling Technology 
Anti-Mouse, HRP Goat Sigma 
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Anti-Mouse, 680 Goat Invitrogen 
Anti-Oaz1 Rabbit Lab collection 
Anti-ODC Rabbit Lab collection 
Anti-PGK Mouse Invitrogen 
Anti-Rabbit, HRP Donkey GE Healthcare, UK 
Anti-Rabbit, 800 Goat Rockland 
Anti-Rat, HRP Goat Abcam 
Anti-Rpn5 Rabbit Lab collection 
Anti-Rpn11 Rabbit Santa Cruz Biotechnology 
Anti-RPT5 Rabbit Abcam 
Anti-TPI Rabbit Lab collection 
3.1.7. Chemicals 
Chemical Supplier 
Acetic Acid Merck 
N1-Acetylspermidine Wako 
N8-Acetylspermidine Wako 
Acrylamide Roth 
Adenine Applichem 
Adenosine triphosphate Apllichem 
Agarose Sigma 
Ammonium persulfate Sigma 
Ampicillin Sigma 
L-Arginine Roth 
Agar MP Biomedicals 
β-Mercaptoethanol Sigma 
Boc-LLR-AMC Bachem 
Bradford-Reagent Bio-Rad 
Bromophenol Blue Serva 
Calcium chloride (CaCl2) Acros 
Chloramphenicol Sigma 
Complete protease inhibitors EDTA free Roche 
Coomassie Biliant Blue R-250 Merck 
Copper (II) sulfate Acros 
Deoxyribonucleotides triphosphate (dNTPs) Sigma 
N1, N8-Diacetylspermidine Wako 
di-Sodiumhydrogenphosphate (Na2HPO4) Roth 
Dimethylformamid (DMSO) Roth 
Dithiothreitol (DTT)  AppliChem 
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Ethanol VWR 
Epoxomycin Enzo life sciences 
FLAG peptide Sigma 
5-Fluoroorotic acid (5-FOA) Sigma 
Formaldehyde Riedel-de Haën 
D(+) Galactose VWR International 
Geneticin disulfate (G418) Sigma 
Glas beads (E. coli) 0.10- 0.11mm Satorius Stedium 
Glass beads (yeast) 0.4- 0.6mm Satorius Stedium 
D(+) Glucose Roth 
Glutathione sepharose 4B GE Healthcare 
Glycerol AppliChem 
Glycine Merck 
L-Histidine AppliChem 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) Serva 
Imidazole Sigma 
L-Isoleucine Merck 
Isopropanol VWR 
Isopropyl-β-D-thiogalactoside (IPTG) Formedium 
L-Leucine AppliChem 
Lithium acetate Alfa Aesar 
L-Lysine Roth 
LumiLight Western Blot Substrate Roche 
Magnesium chloride (MgCl2) Roth 
m-Cresol purple sodium salt Sigma 
Methanol Roth 
L-Methionine Merck 
MG132 Sigma 
Milk powder Roth 
Nourseothricin sulfate Jena bioscience 
Ni-sepharose GE Healthcare 
Polyethylene Glycol (PEG) [3350] Sigma 
Peptone Formedium 
L-Phenylalanine Roth 
Pierce ECL Plus Western blotting substrate Thermo Scientific 
Ponceau S solution Sigma 
Potassium acetate  Merck 
Potassium chloride  Acros 
Potassium dihydrogen phosphate  Roth 
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Sodium dodecyl sulfate (SDS) VWR 
Sodium azide Sigma 
Sodium carbonate Sigma 
Sodium chloride  AppliChem 
Sodium hydroxide  Roth 
Di-sodium hidroxyphosphate  Fluka 
Sodium phosphate  Merck 
Sodium thiosulphate Sigma-Aldrich 
Spermidine Sigma 
Spermine Sigma 
[3H]-Spermidine PerkinElmer 
Suc-LLVY-AMC Bachem 
N, N, N’, N’-tetramethylethylenediamine (TEMED) AppliChem 
L-Threonine Roth 
Tris Roth 
Triton X-100 Sigma 
L-Tryptophan AppliChem 
Tryptone Formedium 
TWEEN 20 Sigma 
Uracil Sigma 
Urea Usb 
Yeast extract powder Formedium 
Yeast Nitrogen Base Formedium 
3.1.8. Instruments 
Major Instruments Source 
Centrifuge Avanti J-20 XP, Optima TLX Ultracentrifuge 120,000-rpm,  
Allegra X-22R, Scintillation counter  LS5000 TD 
Beckman Coulter 
Curix 60-System developer machine  Agfa 
FLUOstar Galaxy Microplate Reader BMG Labtech 
Incubators  New Brunswick 
Mini-gel gel electrophoresis, Blotting chamber Bio-Rad 
Mixer Mill MM400 Retsch 
Odyssey Infrared imaging system LI-COR biosciences, USA LI-COR 
Thermocycler Biometra 
Refrigerated centrifuge 5417R, centrifuge 5415D, Thermomixer 
compact, BioSpectromoter 
Eppendorf 
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3.2. Methods 
3.2.1. Molecular biology and genetic techniques 
3.2.1.1. Isolation of plasmid DNA from E. coli 
E. coli cells harbouring the plasmid of interest were grown overnight (or a minimum of 
7 hours) at 37°C with constant shaking in LB medium supplemented with the 
appropriate antibiotics (ampicillin at 70 µg/ml and chloramphenicol at 34 µg/ml). Cells 
were collected by centrifugation and plasmid DNA was isolated using E.Z.N.A.® 
Plasmid Mini Kit I (Omega Bio-Tek) according to manufacturer’s instructions. 
LB media   
Tryptone 1 %  
Yeast extract 0.5 %  
NaCl 1 %  
Agar (for plates) 2 %   
3.2.1.2. Estimation of DNA concentration 
DNA concentration was measured using the preprogrammed method and Eppendorf 
µCuvette™ in an Eppendorf BioSpectrometer®.    
3.2.1.3. Isolation of genomic DNA from yeast 
Yeast cells were grown overnight at 30°C with constant shaking in 5 ml YPD 
medium. Cells were collected by centrifugation and genomic DNA was isolated using 
E.Z.N.A.® Yeast DNA Kit  (Omega Bio-Tek) according to manufacturer’s instructions. 
3.2.1.4. PCR amplification 
Polymerase chain reaction (PCR) amplification of DNA fragments for cloning was 
performed using the Phusion® High-Fidelity DNA Polymerase (NEB) according to 
manufacturer’s instructions.  
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The PCR reaction mix was set up as follows. 
Component 
100 µL Reaction  Final Concentration 
Ultra pure water (Milli-Q®) to 100 µL  
5X Phusion HF or GC Buffer 20 µL 1X 
10 mM dNTPs 2 µL 200 µM 
100 µM Forward Primer 0.5 µL 0.5 µM 
100 µM Reverse Primer 0.5 µL 0.5 µM 
Template DNA  < 500 ng 
Phusion DNA Polymerase 1 µL 2.0 units/100 µL Reaction  
 
Thermocycling conditions: 
Step Temperature Time 
Initial denaturation 98°C 30 seconds 
Denaturation 
    30X 
98°C 10 seconds 
Annealing Tm-5 30 seconds 
Extension 72°C 30 seconds/kb 
Final extension 72°C 5-10 minutes 
Hold 4°C  
 
PCR products were purified from the reaction mix using the High Pure PCR Product 
Purification Kit (Roche) as per manufacturer’s instructions 
Normal fidelity PCR reactions, were performed using the DreamTaq™ PCR master 
mix (Thermo Scientific) according to the following protocol. This PCR mix contains 
DreamTaq™ DNA polymerase, DreamTaq™ buffer, MgCl2 and dNTPs.For colony 
PCR, the template was prepared by resuspending a small amount of cells (yeast or 
E. coli) in 1 µL of nuclease-free water and boiling it for 1 min.  
The PCR reaction mix was set up as follows. 
Component 100 µL Reaction  Final Concentration 
Ultra pure water (Milli-Q®) to 100 µL  
DreamTaq PCR Master Mix (2X) 50 µL 1X 
100 µM Forward Primer 0.5 µL 0.5 µM 
100 µM Reverse Primer 0.5 µL 0.5 µM 
Template DNA  < 500 µg 
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Thermocycling conditions: 
Step Temperature Time 
Initial denaturation 95°C 5-10 min 
Denaturation  
         30X 
 
95°C 30 seconds 
Annealing Tm-5 30 seconds 
Extension 72°C 1 minute/kb 
Final extension 72°C 5-10 minutes 
Hold 4°C  
3.2.1.5. Agarose gel electrophoresis 
Agarose gel electrophoresis was performed to resolve and analyze DNA samples. 
Optimal separation results were obtained using 0.8-1 % (w/v) agarose gels in TAE 
buffer (40 mM Tris-Cl, 20 mM sodium acetate,1 mM EDTA). The DNA samples were 
mixed with 6X Gel Loading Dye, Purple without SDS (NEB). For visualization of the 
DNA fragments, 1.5 - 2 µL of SERVA DNA Stain G was added to 100 ml of agarose 
gel solution before casting.  The bands were visualized under UV light. Appropriate 
DNA ladders (NEB) were loaded along with the samples for molecular weight 
estimation. 
3.2.1.6. Extraction of DNA from agarose gels 
Elution of DNA fragments from agarose gels was performed after cutting out the 
band of interest from the agarose gel and recovery using the High Pure PCR Product 
Purification Kit (Roche) as per manufacturer’s instructions 
3.2.1.7. Restriction digestion of DNA 
Plasmid DNA and PCR products after purification were digested with sequence-
specific endonucleases. 1 µL of FastDigest™ enzymes (Thermo Scientific) was used 
to cleave 1 µg of substrate DNA in a universal FastDigest buffer. The reaction was 
performed between 5-15 min according to the enzyme used as per manufacturer’s 
instructions. If necessary, the digested DNA fragments were separated by agarose 
gel electrophoresis and purified as described above. 
3.2.1.8. Ligation of DNA fragments 
Ligation of DNA fragments was performed using T4 DNA Ligase (NEB) according to 
the following protocol. A vector: insert molar ratio of 1:4 was used. 
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Ligation mix  
Ultra pure water (Milli-Q®) to 20 µL 
10X T4 DNA Ligase Reaction Buffer 2 µL 
T4 DNA Ligase (NEB) 1 µL 
vector DNA ~ 40 ng 
insert DNA ~ 30 ng 
Ligation mix was incubated for either 1 hour at 22°C or overnight at 4°C prior to 
transformation of competent E.coli cells. 10 µL of the ligation mix was used for 
transformation. 
3.2.1.9. Preparation of chemically competent E.coli cells 
The desired E. coli strain was grown overnight at 37°C in 20 ml LB medium. Sub-
culturing was done in 100 ml LB medium inoculated at OD600= 0.2 and grown till 
OD600= 0.6. This culture was then transferred to pre-cooled 50 ml tubes and 
centrifuged at 900xg for 10 min at 4°C. The supernatant was discarded and 25 ml 
ice-cold, sterile CaCl2 was added to the pellet. The pellet was then gently re-
suspended and incubated on ice for 20 min followed by centrifugation at 900xg for 10 
min at 4°C. The supernatant was discarded and the pellet was re-suspended in 0.1 M 
CaCl2 containing 15% ice-cold glycerol. This mixture was incubated on ice for 1 hour. 
The resulting competent E. coli cells were stored as 50 µL aliquots at -80°C.  
3.2.1.10. Transformation of chemically competent E. coli cells 
50-100 µL of chemically competent E. coli cells were incubated with the desired 
plasmid DNA for 5 min on ice. This mixture was subjected to heat shock at 42°C for 
45 sec and later recovered on ice for 5 min. The recovered cells were resuspended 
in 900-950 µL of LB media without antibiotics and incubated at 37°C with shaking for 
at least 45 min to allow the expression of the antibiotic resistance gene. The cells 
were collected by centrifugation in a table top centrifuge at 18500xg for 2 min and 
plated on LB agar plates supplemented with appropriate antibiotics. The plates were 
incubated at 37°C till colonies appeared. 
3.2.1.11. Cultivation of yeast cells 
Yeast cells were streaked out on either YP or minimal media agar plates and grown 
at 30°C unless otherwise stated. For liquid cultures, cells from single yeast colonies 
were inoculated in liquid YPD, YPGalactose or in selective synthetic media and 
incubated with shaking (160 rpm) at appropriate temperatures. Unless stated 
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otherwise, cultures were grown to exponential phase (OD600=0.8 to 1) by diluting 
the culture in the same media. 
Media compositions are given below. 
YP media  
Yeast extract 1 % 
Peptone 2 % 
Glucose/Galactose 2 % 
Agar (for plates) 2 %  
 
  
 
 
 
 
 
 
Amino acids and nucleobases were added to SD media as required.  
 
 
 
 
 
 
 
 
 
 
 
 
3.2.1.12. Yeast phenotypic analysis by spot tests 
Cells from freshly streaked out yeast colonies were picked using sterile toothpicks 
and resuspended in 400 μL of sterile water and the OD600 was determined. The 
different cell suspensions were diluted with sterile water to an OD600 of 0.5 and 
made up to a total volume of 200 μL. These suspensions or their serial dilutions were 
then transferred to 96-well plates and spotted onto appropriate agar plates using a 
frogger and grown for 2-3 days. 
SD media  
Yeast nitrogen base 
(without amino acids) 
0.67 % (w/v) 
Glucose 2 % 
Agar (for plates) 2 % 
Amino acids and nucleobases  Concentration (w/v) 
L-Arginine 0.002%  
L-Histidine 0.001%  
L-Isoleucine 0.006%  
L-Leucine 0.006%  
L-Lysine 0.004%  
L-Methionine 0.001% 
L-Phenylalanine 0.006% 
L-Threonine 0.005% 
L-Tryptophan 0.004% 
Uracil 0.004% 
Adenine 0.002% 
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3.2.1.13. Yeast mating type testing and crossing of haploids 
In order to cross haploid yeast cells, they were mixed in approximate equal amounts 
on a YPD plate and incubated overnight at 30°C. This was followed by replica-plating 
on selective media were only the diploids would grow. Single colonies were picked 
and re-streaked on selective media to obtain the desired diploids. To test the mating 
type of a haploid yeast strain, the strain was crossed to a different auxotroph 
background strain to test for correct mating types on SD plates. KMY38 (MATα trp5) 
and KMY39 (MATa trp5) were used as tester strains. Haploid cells carrying the trp1-
Δ63 mutation were mated with the mating type tester strains yielding prototrophic 
diploid cells that grew on SD plates without tryptophan. 
3.2.1.14. Sporulation and tetrad dissection 
Sporulation and tetrad dissections were carried out to modify yeast strains. After 
crossing, the diploid strains were grown on YPD plates at 30°C for two days. To 
induce meiosis and sporulation, the cells were inoculated in 3 ml liquid sporulation 
medium (1% potassium acetate, 0.005% zinc acetate, 0.04 mg/ml adenine, 0.02 
mg/ml uracil, 0.006 mg/ml L-leucine, 0.003 mg/ml L-lysin, 0.004 mg/ml L-tryptophan, 
0.002 mg/ml L-histidine) and incubated for 5 days at 25°C, followed by 3 days at 
30°C. 100 μL of the culture were taken, centrifuged for 1 minute at 14000xg at room 
temperature and re-suspended in 200 μL of sterile water. To disrupt the ascus wall, 3 
μL of β-glucoronidase were added to the suspension and incubated for 5 minutes at 
37°C. 20 μL of the suspension were carefully poured onto a YPD plate to form a line 
across the plate. The tetrad dissection was done under a microscope using a 
micromanipulator. After incubation for 2-3 days at 30°C, the spore clones were 
isolated and analysed for genotype and mating type. 
3.2.1.15. High efficiency yeast transformation (Gietz and Woods, 2006) 
Yeast cells were grown to an OD600 of 0.6 to 1.0 in 5 ml of appropriate medium and 
harvested by centrifugation at 3000xg for 5 min. The pelleted cells were 
subsequently washed once with 5 ml of sterile water before adding the following 
transformation mix.  
Yeast transformation mix  
50 % (w/v) PEG-3350 240 µL 
1 M LiAc  36 µL 
E. coli DNA 2 µL 
Plasmid DNA 2.5 µL (each) 
Sterile distilled water to 360 µL 
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The transformation mix was vortexed vigorously for at least a minute until the pellet 
was completely re-suspended. This mixture was then incubated at 30°C for 15 min 
followed by another incubation at 42°C (heat shock) for 15 min. Afterwards, the cells 
were collected by a short-spin and washed with sterile water. In the case of plasmid 
transformation, cells were immediately plated on the appropriate selective medium 
whereas for gene disruptions or modifications, cells were plated on selective medium 
only after incubation in non-selective medium for at least 3 hours. Plates were 
incubated for 2-5 days at 30°C until yeast colonies appeared. 
3.2.2. Biochemical and immunological methods 
3.2.2.1. Yeast cell lysis with glass beads (Dohmen et al., 1995) 
10-50 ml cells were pelleted and re-suspended in 1:1 volume of cold lysis buffer (150 
mM NaCl, 5 mM EDTA, 50 mM HEPES (pH 7.5), 1 % Triton X-100, 1X protease 
inhibitor mixture, EDTA free) and glass beads (0.4- 0.6 mm) at 4°C. The suspension 
was shaken on a Vibrax shaker (VXR basic IKA Vibrax) for 5 min at 2000 mot/min 
4°C. Cells were then briefly centrifuged for 10 seconds. The supernatant was 
collected and marked as “total” lysate. The relative protein amounts were determined 
using Bradford method and the total protein amounts were normalized between 
various samples. The normalized samples were centrifuged at 30000xg for 30 min at 
4°C. In certain cases, the samples were subjected to ultracentrifugation at 35000 rpm 
(Beckman Optima™ TLX ultracentrifuge with rotor TLA-55) for 30 min at 4°C. The 
resultant “pellet” and “supernatant” fractions were separated and transferred to pre-
cooled tubes. The fractions were then boiled with LLB and analysed by SDS-PAGE 
3.2.2.2. Yeast cell lysis by boiling 
Yeast cells were pelleted, resuspended in 2x LLB with 1% β-mercaptoethanol and 
boiled at 100°C for 5 min. Samples were cooled down to room temperature and cell 
debris was pelleted by short centrifugation. 
1x Laemmli loading buffer (LLB)  
Tris-Cl (pH 6.8) 62.5 mM 
SDS 2 % 
Glycerol 10 % 
M-Cresol purple  0.0001 g/ml 
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3.2.2.3. Yeast cell lysis by grinding 
Exponentially growing cultures of yeast cells were centrifuged at 5000xg and washed 
once with distilled water before snap-freezing in liquid nitrogen. Proteins were 
extracted by grinding using a Mixer Mill MM400 (Retsch). The frozen cell pellets were 
placed in one or two grinding jars containing grinding balls all of which were pre-
cooled with liquid nitrogen. Radial oscillations in a horizontal position were done for 1 
min at 30 Hz. The resulting cell powder was transferred to a 50 ml falcon tube, frozen 
in liquid nitrogen and stored at -80°C until further analysis.  
3.2.2.4. Estimation of protein concentration 
To estimate the protein concentration, 2- 4 μL of samples was made up to a volume 
of 800 μL using distilled water and mixed with 200 μL of Bradford reagent (BioRad). 
This mixture was incubated for 5 min at room temperature. Bradford reagent contains 
coomassie brilliant blue G which changes its absorbance maximum from 465 nm to 
595 nm upon binding to protein. The absorbance of samples to be assayed was 
measured at 595 nm and correlated to a protein standard curve that was obtained 
with BSA solutions. For purified proteins, the concentrations were measured using 
the Eppendorf µCuvette™ in an Eppendorf BioSpectrometer®. The programmes 
were set for each protein/protein complex based on their corresponding extinction 
coefficients. 
3.2.2.5. SDS polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970) 
Protein extracts were analysed by SDS-PAGE using a standard protocol. The 
composition of resolving and stacking gels are given below.   
 
Resolving gel  
Acrylamide/bisacrylamide (37:5:1) 10% or 12% (w/v) 
Tris-HCl pH 8.8 375 mM 
SDS 0.1% (w/v) 
APS 0.05% (w/v) 
TEMED 0.033% (v/v) 
Stacking gel  
Acrylamide/bisacrylamide (37:5:1) 4% (w/v) 
Tris-HCl pH 6.8 125 mM 
SDS 0.1% (w/v) 
APS 0.05% (w/v) 
TEMED 0.055% (v/v) 
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After casting the resolving gel, it was overlayed with isopropanol and allowed to fully 
polymerize. The gel was then gently washed with water to remove the isopropanol. 
The stacking gel was casted on top of the resolving and combs with the desired 
number of wells were inserted. The samples were loaded onto the wells along with a 
protein ladder for molecular weight determination (PageRulerTM Plus Prestained 
Protein Ladder). After electrophoresis, gels were subjected to either western blot 
analysis or directly stained with coomassie brilliant blue R 250. 
Coomassie blue R-250 staining solution  
Methanol 40% (v/v) 
Acetic acid 10% (v/v) 
CBB-R250 0.025% (w/v) 
Destaining solution  
Methanol 40% (v/v) 
Acetic acid  10% (v/v) 
The gels were incubated in staining solution for 10-30 minutes and destained for up 
to 24 hours till clear protein bands appeared. 
3.2.2.6. Western blot analysis 
Western blotting was done to analyse proteins after separation by SDS-PAGE or 
Native-PAGE. The proteins were first transferred from the gel to either a 
nitrocellulose or a PVDF membrane using the semi-dry protein transfer system (Bio-
Rad) using the transfer buffer (25 mM Tris-HCl pH 8.3, 192 mM glycine, 20% (v/v) 
methanol). A current of 0.8 mA/cm2 was applied for 75 min for efficient transfer of 
proteins. After transfer, the membrane was incubated in blocking solution (3% milk in 
PBS) for 1 hour. The membrane was then incubated overnight at 4°C with specific 
primary antibodies diluted in blocking solution. The next day, the membrane was 
washed for 4 times (5 min duration each) with either 1x PBST (for ECL detection) or 
1x PBS (for Odyssey detection) before incubation with secondary antibody coupled 
to HRP (for ECL detection) or fluorophores 800 nm, 680 nm (for Odyssey detection) 
for 1 hour. Finally, the membrane was washed 4 times (5 min each) with either 1x 
PBST or PBS. For ECL detection, the membrane was incubated with Lumi-light Plus 
reagent (Roche) for 1 min before exposing to light sensitive X-ray film. For 
membranes probed with the fluorophore-coupled secondary antibody, the signal was 
detected by using the Odyssey Infrared imaging system (LI-COR). The signal was 
visualized and quantified using the Odyssey v1.2 software.  
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3.2.2.7. Reprobing of western blot membranes 
Western blot membranes were stripped off their original antibodies and reprobed with 
different primary antibodies to visualize several proteins on the same membrane. The 
membrane was initially washed with 0.2 N NaOH for 15 min and then with water to 
remove bound antibodies. It was then incubated for 10 min with blocking solution 
followed by incubation with primary and secondary antibodies as described above.  
3.2.2.8. Analysis of protein stability by cycloheximide chase 
Cycloheximide, an inhibitor of protein biosynthesis was used to analyse the stability 
of proteins in log-phase yeast cultures.  Yeast cells were grown to an OD600 of 0.6-
0.8 and 100 μg/ml of cycloheximide was added to block protein translation. Cells 
were harvested at different time points after cycloheximide addition and lysates were 
prepared by glass-bead or boiling method. The samples were further analysed by 
SDS-PAGE and western blotting. 
3.2.2.9. ODC-Oaz1 interaction analysis 
For analysis of ODC-Oaz1 interactions, proteins were extracted from E. coli BL21 
cod+ cells harbouring either pDG241 (GST-Oaz1), pGEX-2TX (GST), pDG273 
(ODC-Flag) or pUC19 (mock) by glass bead lysis in ice-cold lysis buffer (50mM Na-
HEPES (pH 7.5), 5mM EDTA, 1% Triton X-100) containing protease-inhibitor cocktail 
(Roche). Total protein amounts were equilibrated between GST-Oaz1 and GST 
lysate using the mock lysate. 800 µg of total proteins were incubated with 100 µL of 
glutathione beads (GE Healthcare) at 4°C for 2h. From this step onwards, 1 mM 
spermine was added to certain tubes as indicated in Fig.11. The beads were washed 
two times with lysis buffer, and further incubated after the addition of ODC-Flag 
lysate at 4°C for 2h. Bound proteins were eluted by incubation with 125 µL elution 
buffer [25 mM Glutathione (Sigma), 20 mM NaOH in lysis buffer] at 4°C for 90 min. 
The samples were then analysed by SDS-PAGE and western blotting as described 
above.  
3.2.2.10. Purification of proteasomes from yeast (Ha et al., 2012) 
26S proteasomes were purified from yeast strain MO24, in which the PRE1 gene, 
encoding the 20S core particle subunit Pre1, has been stably modified to express a 
C-terminally Flag-6His tagged version. 3 L of yeast culture was grown to an OD600 
of 2, divided into 3 equal parts and harvested by spinning at 3500xg for 8 min at 4°C. 
Each pellet was washed once with 40 ml cold water before snap freezing in liquid 
nitrogen. Lysis was carried out using using a Mixer Mill MM400 (Retsch) as 
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described above. The yeast cell powder was collected in a 50 ml tube, snap-frozen 
and stored at -80°C. The pellet was thawed by adding 2 pellet volumes of Buffer A 
(50mM Tris.Cl, pH 7.5, 150 mM NaCl, 10% Glycerol, 0.2% Triton-X-100) containing 
4mM ATP and 1x ARS (buffer AAA). This mixture was incubated in ice till complete 
suspension of the pellet (approx. 45 min) followed by centrifugation in an pre-cooled 
Beckman 25.50 rotar for 20 min at 17000 rpm at 4°C. The supernatant was filtered 
using a Acrodisc PF Syringe Filters with Supor Membrane (0.2 µ 0.8/0.2 µm, 32 mm) 
into a pre-cooled 15 ml tube. Anti-Flag agarose beads (1ml/15,000 OD) were 
equilibrated by washing twice with 5 volumes of buffer AAA with alternating 
incubations at 4°C for 5 min. The beads were collected by spinning at 200xg for 3 
min. The filtered supernatant was then added to the pre-equilibrated anti-FLAG 
agarose beads and incubated at 4°C for 3h in a rotating wheel. The beads were 
collected by spinning at 200xg for 3 min. The beads were washed twice with 5 
volumes of buffer AAA (with 5 min mild rotation at 4°C) and rinsed (re-suspended 
and pelleted without incubation) twice with 5 volumes of buffer B (25 mM HEPES, pH 
7.8, 5 mM MgCL2, 25 mM KCl, 10% glycerol) supplemented with 2 mM ATP (buffer 
BA). The bound proteasomes were eluted with 300 µL of buffer BA containing 150 
µg/ml of Flag peptide, transferred to a 2 ml tube and incubated at 4°C for 1h in a 
rotating wheel. If necessary, elution was repeated with another 300 µL of elution 
buffer.  
3.2.2.11. Purification of Oaz1, ODC and ODC/Oaz1 heterodimer 
6His-Oaz1 was affinity-purified from E. coli strain Rosetta (Merck) transformed with 
pDG240 (6His-Oaz1) as described earlier (Kurian et al., 2011). Cells were grown in 
LB medium supplemented with ampicillin and chloramphenicol to OD600=0.6 and 
expression was induced by adding 1mM IPTG for 4h. Cell were harvested and re-
suspended in 10 ml binding buffer (50 mM Tris, pH 7.8 at 4 °C). This mixture was 
frozen in liquid nitrogen and stored at −80 °C. For lysis, the cells were thawed in 
water and 10 mg of lysozyme (Sigma), 1 mg of DNase I (Roche) and 1X protease 
inhibitor mix (Roche) were added. Lysis was initiated by vortexing six times for 10 sec 
at 25 °C followed by incubation on ice for 45 min. The lysate was then clarified by 
centrifugation at 25000xg for 30 min at 4 °C. Amylose resin (200 µL; NEB) was 
equilibrated with binding buffer before adding the supernatant. This suspension was 
incubated for 2h at 4 °C for with mild rotation. Unbound material was removed by 
centrifugation at 200xg for 3 min at 4 °C. The beads were washed five times with 
10 ml of binding buffer supplemented with 20 mM imidazole. Bound protein was 
eluted in 350 µl binding buffer containing 250 mM imidazole for 1h at 4 °C for with 
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mild rotation. 6His-Oaz1/ODC-2xha or 6His-Oaz1-ΔODS-ODC-2xha were co-
expressed in E. coli strain Rosetta and Ni-affinity-purified as described above with a 
few variations. The lysis buffer used was buffer B (25 mM Na-HEPES, pH 7.8, 5 mM 
MgCL2, 25 mM KCl, 10% glycerol). After elution of the protein, imidazole was 
removed using NAPTM-5 (GE Healthcare) columns. The purity of the eluted proteins 
was evaluated by SDS-PAGE followed by coomassie staining. The purified proteins 
(in buffer with 10% glycerol) were stored as 20-50 µL aliquots at -80 °C.  
3.2.2.12. Analysis of proteasomes by Native-PAGE (Elsasser et al., 2005) 
The purity and of the proteasomes were analysed by Native-PAGE followed by either 
coomassie staining or in-gel chymotrypsin-like activity degradation assay.  
The composition of the gel is given below. 
Native gel  
Acrylamide/bisacrylamide (37:5:1) 3.5%(w/v) 
Tris 90 mM 
Boric acid 90 mM 
MgCl2 5 mM 
EDTA 0.5 mM 
ATP- MgCl2 1 mM 
APS 0.1% (w/v) 
TEMED 0.1% (v/v) 
10-15 ml of the above gel mixture was used to prepare 1 mini native gel. The gel was 
cast at room temperature and was later allowed to cool down at 4°C. The samples 
were prepared in 5x sample buffer (250mM Tris-HCl, pH 7.4 50% glycerol, 60 ng/ml 
xylene cyanol). After sample loading the gels were run at 4°C at 100 V for 3 h. After 
separation, proteasomes was detected by an in-gel proteasome assay using Suc-
LLVY-AMC (N- succinyl- leucine- leucine- valine- tyrosine- 7- amino- 4- methyl 
coumarin), or by coomassie staining.  
The in-gel proteasome activity assay was performed by incubating the gel in the 
following solution for 10 min at 30°C.  
Tris-HCl pH 7.4 25 mM 
MgCl2 10 mM 
ATP 1 mM 
DTT 1 mM 
Glycerol 10% (v/v) 
Suc-LLVY-AMC 0.1 mM 
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Proteasome bands were visualized upon exposure to a UV lamp and imaged using a 
Gel Doc™ (Bio-Rad). 20S bands can be visualised better with addition of 0.002% 
SDS to the assay mixture. 
3.2.2.13. Proteasomal peptidase activity assay (Dohmen et al., 2005) 
The chymotrypsin-like proteasomal activity assay was done by measuring the 
release of the fluorescent 7 amino-4-methylcoumarin (AMC), after cleavage from 
Suc-LLVY-AMC, at 440 nm by using an excitation wavelength of 380 nm. 0.06 µg of 
purified 26S proteasome and varying amounts of spermine (as shown in Fig. 10B) 
were diluted in buffer B supplemented with 1 mM ATP and 1 mM DTT  to a volume of 
90 μL followed by addition of 10 μL of 1:10 dilution of substrate stock solution (10 
mg/ml). The reactions were set up in a 96 well plate and measured using a 
fluorimeter (FLUOstar Galaxy Microplate Reader). The measurement was done in 40 
cycles and the enzymatic activity in each fraction was calculated based on the 
increase of fluorescence per time.  
3.2.2.14. In vitro proteasomal degradation assay (Ha et al., 2012) 
A degradation assay was set up in a 15 μL reaction containing purified proteasomes 
and ODC/Oaz1 heterodimer as substrate in buffer B (25 mM HEPES, pH 7.8, 5 mM 
MgCL2, 25 mM KCl, 10% glycerol) supplemented with 1 mM ATP and 1 mM DTT. 
The amounts of 26S proteasome and substrate used are as indicated in Figs. 8 and 
9.  To inhibit proteasomal activity; proteasomes were pre-treated with 100 µM 
epoxomycin (Enzo life sciences) at 30°C for 45 min before adding to the degradation 
assays. Wherever indicated (Fig. 9), the reactions were supplemented with either 
spermidine or spermine. The degradation reactions were carried out at 30°C for 
various time periods as indicated in Figs. 8 and 9 followed by SDS-PAGE and 
western blotting.  
3.2.2.15. Polyamine binding assay (Palanimurugan and Dohmen, 2012) 
Polyamine binding mixtures were composed of 10 μM of purified 6His-Oaz1 mixed 
with 10 μM of [3H]-spermidine and one of the three acetyl polyamines N1-
acetylspermidin, N8-acetylspermidine and N1, N8-diacetylspermidine (concentrations 
as indicated in Fig.13A) and made up to 100 μL with 50 mM Tris, pH 7.8 at 4 °C. This 
was then gently mixed and incubated on ice for 60 min. This mix was then 
transferred to a centrifugal filter (modified polyethersulfone (PES) 10K, VWR) 
mounted on top of a 1.5 ml collection tube. The unbound polyamines were filtered by 
spinning at 2500xg for 5 min at 4°C. Microcentrifuge tubes with 1 ml scintillation liquid 
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(two tubes with scintillation liquid for every filter device used) were prepared and kept 
at room temperature. 10 μL of the retentate from inside the cut-off filter device was 
removed and added to a microcentrifuge tube with scintillation liquid (retentate). 
Next, 10 μL of filtrate from the collection tube of the filtration device was added to a 
second microcentrifuge tube with scintillation liquid (filtrate). The tubes were vortexed 
for 10s before proceeding with scintillation counting. From the resulting CPM (counts 
per minute) values, the percentage of protein-bound polyamines was calculated 
using the following formula. 
Percentage polyamine Binding = {(CPMretentate- CPMfiltrate)/ CPMretentate} x 100 
3.2.2.16. Native-PAGE analysis of proteasomal binding 
The binding mixture was prepared similar to the degradation assay mixture. 4 µg of 
26S proteasome and 50 ng of substrate were mixed in 10 µL buffer B supplemented 
with 1 mM ATP and 1 mM DTT and 50 µM MG132. The latter inhibitor was added to 
prevent any degradation of the substrates by the proteasomes. This mixture was 
incubated in ice for 3h. 2.5 µL of 4x Native PAGE sample buffer (Life technologies) 
was added and mixed with the sample. This mixture was then centrifuged at 30000xg 
for 10 min to remove all insoluble material that might interfere with the Native PAGE. 
The samples were analysed using the NativePAGETM Novex® Bis-Tris Gel System 
(Life technologies) followed by western blotting as per manufacturer’s instructions.  
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4. Results  
4.1. Characterization of the direct role of polyamines in ODC targeting 
Polyamines regulate cellular ODC levels by two known mechanisms involving ODC 
antizyme. They induce ribosomal frameshifting during the translation of antizyme and 
also inhibit the ubiquitin-dependent degradation of antizyme (Kurian et al., 2011; 
Palanimurugan et al., 2004). However, there is a third possible mechanism of 
regulation of ODC by polyamines. Using a stable mutant of antizyme (Oaz1-4res), 
Gödderz showed that polyamines directly enhanced the degradation of ODC in vivo 
(Gödderz, 2010). The Oaz1-4res mutant [in frame version (Palanimurugan et al., 
2004)] was used because its levels were not altered by polyamine addition. Upon 
addition of spermidine, the steady state levels of ODC was lowered albeit similar 
antizyme levels indicating a direct enhancement of ODC degradation by polyamines. 
This observation was further clarified using wild-type Oaz1 (in frame version). The 
presence of spermidine caused a remarkable decrease in ODC levels in spite of 
similar Oaz1 levels established using a copper-inducible, PCUP1 promoter-driven 
OAZ1 gene.  These data showed that polyamines directly promote ODC degradation 
in vivo in yeast cells (Beenukumar et al., in press). 
4.1.1. In vitro recapitulation of proteasomal degradation of ODC 
To study the direct effect of polyamines on ODC degradation, it was a goal of the 
present work to reconstitute ODC degradation in vitro. Hoyt et al. have previously 
reproduced key features of ubiquitin-independent ODC degradation using mouse 
ODC and purified 26S proteasome (Hoyt et al., 2003). Moreover, another in vitro 
study using yeast ODC and Oaz1 had shown that antizyme promotes ODC 
degradation in a ubiquitin-independent and ATP-dependent manner (Porat et al., 
2008). Subsequently, Gödderz et al. showed using in vivo experiments in yeast that 
binding of ODC monomers to antizyme is required to expose an N-terminal degron of 
yeast ODC called ODS (ODC Degradation Signal) (Godderz et al., 2011). Here, I 
reconstituted ODS-dependent degradation of ODC in vitro. 26S proteasomes were 
affinity-purified using anti-Flag beads from a yeast strain with a Flag-His6-tagged 
β4/Pre1 subunit. Native-PAGE analysis showed that these preparations mainly 
yielded active forms of the proteasome in its singly (SC) or doubly capped (DC) form, 
i.e. CP with one or two RPs (Fig. 7A) (Elsasser et al., 2005). ODC/Oaz1 or ΔODS-
ODC/Oaz1 heterodimers were affinity-purified using Ni-NTA beads from E. coli cells 
overexpressing 6His-Oaz1 and ODC-2xHa or ΔODS-ODC-2xHa and characterized 
by SDS-PAGE. ODC-2xHa purified as a double band, the faster migrating form of 
which apparently, due to premature termination or to proteolytic processing, lacks 
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one of the Ha epitopes as it is not detected with the same sensitivity as the slower 
migrating form (compare Figs. 7B and 8A). The different ODC/Oaz1 heterodimers 
were mixed with 26S proteasomes in a buffer supplemented with ATP, and incubated 
at 30⁰C for specific time periods followed by SDS-PAGE analysis. As expected, ODC 
was degraded over time, whereas antizyme remained stable (Fig. 8A; lanes 4-6). In 
the control without 26S proteasomes, in contrast, ODC was not degraded (Fig. 8A; 
lanes 1-3). Around 75% inhibition of degradation was observed upon addition of 
epoxomicin (Meng et al., 1999), a selective proteasome inhibitor (Fig. 8A; lanes 7-9). 
In a similar experiment using the ΔODS variant of ODC, only around 30% 
degradation was observed compared to the 80% degradation observed for the full-
length ODC (Fig. 8B). These results show that ODS is critical for efficient degradation 
of ODC in line with the in vivo data reported earlier (Godderz et al., 2011). 
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Fig. 7: Purification of 26S proteasome and ODC/Antizyme heterodimer. (A) Flag-tagged 
proteasome affinity-purified from yeast cells was analyzed by native-PAGE and coomassie staining 
(left) or activity staining by overlay with the fluorogenic peptide Suc-LLVY-AMC (right). Proteasomes 
in this preparation were either doubly-capped (DC) with two RPs on both sides of the core particle 
(CP), or singly-capped (SC) with only one RP attached to the CP. 20S CPs without any RPs attached 
to them were also present in the preparation. (B) SDS-PAGE analysis and coomassie staining of 
6His-Oaz1 co-purified from E.coli cells as heterodimers either with full length ODC (ODC-2xHa) or 
with N-terminally truncated ODC lacking the first 47 residues (ΔODS-ODC-2xHa).             
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Fig. 8: In vitro characterization of proteasomal degradation of ODC. (A) In vitro degradation 
assays with purified 26S proteasomes and purified ODC/Oaz1 heterodimer as a substrate showing 
the degradation of ODC over time. 50 ng of ODC/Oaz1 heterodimer (40 nM) and 3 µg of 26S 
proteasome (80 nM) in a volume of 15 µL were used. As controls, otherwise identical samples were 
assayed without 26S proteasome (-26S), or with the proteasome inhibitor epoxomycin (100 µM). In 
the graph, values for the 0 time points were set to 100%. Error bars, s.d.; n = 3. (B) Experiments were 
performed as described for Fig. 8A, except that ΔODS-ODC-2xHa was used instead of the full length 
ODC. 
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4.1.2.  Polyamines directly promote proteasomal degradation of ODC in vitro 
I used the in vitro ODC degradation system described above to study the direct 
effects of polyamines on ODC degradation. Consistent with the in vivo results, 
increased degradation of ODC was observed with increasing concentrations of either 
spermidine or spermine (Fig. 9). Spermine showed a greater effect on ODC 
degradation than spermidine. This finding is compatible with the higher binding 
affinity of Oaz1 observed for spermine compared to spermidine (Kurian et al., 2011).  
 
Fig. 9: Degradation of ODC by the proteasome is directly enhanced upon polyamine addition. 
In vitro degradation of ODC with 0.06 µg of 26S proteasome (1.6 nM) and 100 ng of ODC/Oaz1 (80 
nM) as substrate in a volume of 15 µL as described in Fig. 8A except that varying concentrations of 
either spd or spermine (spm) were added as shown. The graph shows the quantification of ODC-
2xHa signals. Error bars, s.d.; n = 3. Paired T test values are represented as asterisks above the 
bars; P ≤ 0.05 (*) and P ≤ 0.01 (**). 
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4.1.3. Polyamines do not enhance ubiquitin-dependent proteasomal 
degradation 
To investigate the specificity of the observed effect of polyamines on ODC 
degradation, I asked if polyamines have any general effect on proteolytic 
degradation. To address this possibility in vivo, two well characterized ubiquitin-
dependent substrates, an N-end rule substrate (Ub-R-eK-Ha-Ura3) and a Ubiquitin 
Fusion Degradation (UFD) pathway substrate (Ub-V76-eK-Ha-Ura3) were used 
(Ghislain et al., 1996; Varshavsky, 1996). No significant effect on degradation of 
these two substrates was observed upon polyamine addition to polyamine-depleted 
cells (Fig. 10A). Additionally, the chymotrypsin-like activity of purified 26S 
proteasome was measured in the presence of increasing spermine concentration. A 
small reduction in proteasome activity was observed with polyamine addition (Fig. 
10B). Taken together, the results presented above demonstrate that polyamines 
directly and specifically enhance ODC degradation by the proteasome.  
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Fig. 10: Polyamines do not enhance the degradation of ubiquitin-dependent substrates by the 
proteasome. (A) Western blot analysis of steady state levels of Ub-R-e
k
-Ha-Ura3 and Ub-V76- e
k
-Ha-
Ura3 from wild-type cells grown in the presence of 5 mM DFMO. 20 µM spermidine (spd) was added 
as indicated. Ha signals were quantified normalized to the Cdc11 loading controls and given relative 
to the level of protein without spermidine, which was set to 100%. Error bars, s.d.; n = 2. (B) Assay of 
chymotrypsin-like activity with purified proteasome in the presence of increasing spermine (spm) 
concentrations. Error bars, s.d.; n = 4. 
Cdc11
Ub-V76-ek-Ha-Ura3
Ub-R-ek-Ha-Ura3
N-end rule       UFD
5 mM DFMO
̶              +              ̶ +          20 µM spd
A
0
5
10
15
20
25
0 200 400 600 800
C
h
ym
o
tr
p
si
n
-l
ik
e 
 a
ct
iv
ty
µ
m
o
le
s/
m
in
Spm conc in µM
0
20
40
60
80
100
120
re
la
ti
ve
 p
ro
te
in
 a
m
o
u
n
ts
N-end rule
0
20
40
60
80
100
120
140
re
la
ti
ve
 p
ro
te
in
 a
m
o
u
n
ts
UFD
0 spd
20 µM spd
B
  Results 
 
44 
 
4.1.4. Polyamines do not alter the affinity of ODC/antizyme interaction 
To understand the mechanism behind the effect of polyamines on ODC degradation, 
I tested whether polyamines changed the affinity of ODC/Oaz1 heterodimer 
interaction. To address this question, I performed co-pull down assays using epitope-
tagged variants of ODC and Oaz1 expressed in E. coli. GST-Oaz1 bound beads 
were exposed to E. coli cell extracts overexpressing ODC-Flag in the presence or 
absence of spermine. Western blot analysis after GST pull down showed no 
significant difference in ODC-Flag binding between the samples with and without 
spermine (Fig. 11). These data suggested that polyamines promote ODC 
degradation without altering ODC/Oaz1 heterodimer interactions.  
 
Fig. 11: Spermine does not affect the affinity of ODC/antizyme heterodimer. Co-pull down of 
Oaz1 and ODC in the presence or absence of 1 mM spermine (spm). Extracts from E. coli cells 
expressing the indicated tagged proteins were subjected to GST-pull down and subsequent 
quantitative anti-Flag western blotting for ODC-Flag detection and anti-GST for GST-Oaz1 detection. 
ODC-Flag signals after elution were normalized to GST-Oaz1 signals providing ODC-Flag values 
obtained in the absence of spermine, the mean of which was set to 100%. Values obtained in the 
presence of spermine are given in % of those obtained in its absence. Error bars, s.d.; n = 3. 
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4.1.5. Both spermidine and spermine promote antizyme and ODC degradation 
in vivo 
As spermine binds antizyme better than spermidine (Kurian et al., 2011) and also 
shows a greater effect on the enhancement of ODC degradation in vitro, I questioned 
whether spermine is the major mediator of ODC regulation in yeast cells. Therefore, I 
compared the effect of spermidine and spermine on antizyme stabilization and ODC 
degradation in wild-type and spe4-Δ strains. SPE4 encodes spermine synthase, an 
enzyme that mediates the conversion of spermidine to spermine. Hence, spe4-Δ 
cells are devoid of spermine (Hamasaki-Katagiri et al., 1998). Antizyme degradation 
was similarly inhibited in both WT and spe4-Δ cells upon addition of spermidine or 
spermine (Fig. 12, top panel). When compared to spermine, addition of spermidine 
had a stronger effect on the inhibition of antizyme degradation in both strains. 
Similarly, spermidine had a stronger (stimulatory) effect on ODC degradation than 
spermine (Fig. 12, middle panel). These results suggest that both spermidine and 
spermine are capable of mediating ODC regulation in yeast cells. The relatively weak 
effect of spermine on ODC targeting in vivo contrasts with its relatively stronger effect 
in vitro and is likely due to a lower uptake efficiency of spermine by yeast cells (Erez 
and Kahana, 2001). 
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Fig. 12: Role of polyamine subtypes and their modification in the targeting of ODC. Western 
blot analysis comparing steady state levels of Oaz1 and ODC in either the wild-type or a strain lacking 
spermine synthase (spe4-Δ), grown with or without polyamine supplementation as indicated. The 
graph shows the results of a quantification of Myc (upper part) and Ha signals (lower part) normalized 
to the Cdc11 loading control. Levels are given relative to the respective levels of the same proteins in 
cells grown without polyamine addition, which was set to 100%. Error bars, s.d.; n = 3. 
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4.1.6. Acetylation of polyamines inhibit their binding to antizyme 
In mammals, when cellular polyamine levels are high, they are acetylated leading to 
their breakdown or export from the cells (Casero and Pegg, 1993). High cellular 
polyamine levels, in addition, lead to antizyme synthesis and hence the down-
regulation of ODC. I therefore asked whether acetylated polyamines might be 
responsible for down-regulating ODC by binding to antizyme. Hence a competition 
assay with [3H]-spermidine and various acetylated spermidine for Oaz1 binding was 
performed. In this assay, mono-acetylated spermidine variants showed a clearly 
reduced binding to antizyme when compared to unmodified spermidine, and di-
acetylspermidine showed no competition at all (Fig. 13A). I then asked if acetylated 
polyamines affected either antizyme or ODC degradation using the paa1-Δ mutant. 
PAA1 encodes polyamine acetyltransferase, an enzyme that has been shown to 
acetylate polyamines (Liu et al., 2005). No notable differences were observed 
between WT and paa1-Δ yeast cells in antizyme stabilization and ODC degradation 
(Fig. 13B). Taken together, these findings suggest that once acetylated, polyamines 
do no longer participate in the feedback regulation of ODC.  
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Fig. 13: Role of acetylated polyamines in the feedback regulation of ODC. (A) Acetylation of 
spermidine inhibits its binding to antizyme. In vitro binding assay showing the competition between 
[
3
H]-spermidine and different species of acetylated spermidine for binding to 6xHis-tagged antizyme 
purified from E. coli. (B) Western blot analysis after SDS-PAGE comparing steady state levels of 
Oaz1 and ODC in either the wild-type or a strain lacking polyamine acetyltransferase (paa1-Δ), grown 
with or without 100 µM spermidine as indicated. The graph shows the results of a quantification of 
Myc (left) and Ha signals (right) normalized to the Cdc11 loading control. Levels are given relative to 
the respective levels of the same proteins in cells grown without polyamine addition, which was set to 
100%. Error bars, s.d.; n = 3. 
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4.2. Characterization of ubiquitin-independent substrate recognition by the 
proteasome 
Ubiquitin-dependent substrates have well-characterized proteasomal receptors that 
recognize polyubiquitin chains (Finley et al., 2012). However, how ubiquitin-
independent substrates get recognized by the 26S remains elusive. Several 
hypotheses have been put forth by various laboratories to explain ubiquitin-
independent proteasomal recognition. Zhang et al. suggested that ubiquitylated 
substrates and ODC-antizyme compete for the same binding sites on the 
proteasome (Zhang et al., 2003). Inobe and Matouschek suggested in a recent 
review that ubiquitin-independent substrates have unstructured domains which 
themselves have sufficient binding affinity to the ATPase ring loops thereby 
eliminating the requirement for ubiquitin (Inobe and Matouschek, 2014). In this 
chapter, I explored some of these hypotheses using ODC and other ubiquitin-
independent substrates.  
4.2.1. ODS is essential for proteasomal binding of ODC 
Gödderz et al. showed that ODS is a transplantable and replaceable degron and that 
it’s exposure is essential for ODC degradation (Godderz et al., 2011). For ubiquitin-
dependent proteasomal substrates, binding to the proteasome is mediated by 
polyubiquitin chains and the unstructured region engages the ATPases for substrate 
translocation and unfolding (Lander et al., 2012; Prakash et al., 2004). For ODC 
degradation, it remains unclear whether the unstructured region simply engages the 
ATPases or also takes over the role of ubiquitin and mediates proteasomal binding. 
To answer this question, a blue native PAGE-based in vitro binding assay of purified 
ODC/Oaz1 heterodimer to purified 26S proteasome was developed as shown in 
Fig.14. Using this assay, I recapitulated the binding of ODC/Oaz1 heterodimer to the 
26S proteasome as shown by the superimposition of the Ha signal (ODC-2xHa) with 
the signals from various proteasome specific antibodies (Fig. 15; lane 5). As 
expected, the co-migration of the substrate with the 26S proteasome band was lost in 
the case of the ΔODS variant as well as of the ODC homodimer (Fig.15; lanes 6 and 
7) showing that ODS is essential for proteasome association of ODC/Oaz1 
heterodimer. However, this assay does not exclude the presence of another binding 
element in the heterodimer such as the antizyme.  
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Fig. 14: Schematic representation of the blue native PAGE analysis of binding. A low molecular 
weight test substrate tagged with an epitope is mixed with 26S proteasomes and then separated on a 
3-12% bis-tris BN PAGE gel. Western blot analysis after BN PAGE with the anti-epitope antibody 
would reveal the migration of the test substrate along with the proteasome, if binding occurs.   
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4.2.2. Proteasomal lid is dispensable for in vitro degradation of ODC by the 
proteasome 
Gödderz et al. showed that the lid subcomplex is not required for ubiquitin-
independent degradation of ODC in yeast cells (Godderz et al., 2011). They studied 
the steady state levels of ODC in the rpn5-ΔCT strain in which lid formation was 
impaired without affecting the base subcomplex (Isono et al., 2007). Steady state 
ODC levels were not altered whereas the levels of R-DHFR-2xHa, a ubiquitin-
dependent substrate were increased. These data suggested that the lid subcomplex 
might be dispensable for ODC degradation. However, it is possible that the residual 
amounts of lid in the rpn5-ΔCT mutant were enough to carry out ODC degradation.  
To address this question, 26S particles lacking the lid subcomplex were isolated from 
yeast cells, and ODC degradation using ODC/Oaz1 heterodimer as a substrate was 
carried out as described in subsection 4.1.1. The absence of the lid and the presence 
of other subcomplexes in the proteasome preparation were confirmed using various 
proteasome-specific antibodies as shown in Fig. 16.  As anticipated, ODC was 
degraded both by the normal 26S particles as well as by proteasomes lacking the lid 
(26S-lid), whereas the antizyme remained stable. This observation further reinforces 
the in vivo data from Gödderz et al. that the lid is dispensable for ODC degradation.  
                                      
Fig. 16: In vitro degradation of ODC by 26S proteasomes lacking the lid subcomplex. 
Western blot analysis after SDS-PAGE showing in vitro degradation of ODC with purified 26S 
particles and 26S particles lacking the lid (26S-lid). ODC-2xHa and 6His-Oaz1 was detected 
with anti-Ha and anti-Oaz1 antibodies, respectively. The blot was reprobed with antibodies 
against the different proteasome subunits as indicated. 
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4.2.3. ODC is not recognized by the canonical ubiquitin receptors 
Zhang et al. showed that both substrate-linked and free polyubiquitin chains compete 
with mouse ODC for degradation and therefore suggested that ODC might also be 
recognized by ubiquitin receptors at the proteasome (Zhang et al., 2003). 
Conversely, Gödderz showed that steady-state levels of ODC are reduced in mutants 
lacking one or a combination of ubiquitin receptors suggesting that ubiquitin 
receptors might not recognize ODC (Gödderz, 2010). It is however possible that 
multiple ubiquitin receptors might be involved in ODC reception at the proteasome. 
Therefore, steady state levels of ODC were checked in a strain lacking multiple 
ubiquitin receptors and shuttle factors. This strain lacks the shuttle factors Rad23 and 
Dsk2 and the ubiquitin interaction motifs of the intrinsic ubiquitin receptors, Rpn10 
and Rpn13. The steady state levels of ODC were drastically reduced in the mutant 
strain compared to wild-type. Upon induction of ODC degradation with 100 µM 
spermidine, the ODC levels in the mutant were further reduced. Taken together, the 
data suggest that ODC recognition at the proteasome is not mediated by the 
canonical ubiquitin receptors and that the faster degradation of ODC in these 
mutants might be due to reduced competition with ubiquitylated substrates at a step 
downstream of proteasomal reception.   
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Fig. 17: ODC is degraded faster in a mutant lacking multiple ubiquitin receptors. Western blot 
analysis after SDS-PAGE comparing steady state levels of ODC in wild-type versus the mutant  
rad23-∆ dsk2-∆ rpn10-∆UIM rpn13-∆KKD grown with or without 100 µM spermidine as indicated. The 
graph shows the results of a quantification of Ha signals normalized to the Cdc11 loading control. 
Levels are given relative to the respective levels of ODC-2xHa in cells grown without polyamine 
addition, which was set to 100%.  
4.2.4. Human p21 is degraded by the yeast proteasome and competes with 
ODC for degradation 
p21, the cyclin-dependent kinase inhibitor, is a critical cell cycle regulator in 
mammals (Sherr and Roberts, 1999). p21 is tightly regulated at the level of its 
transcription as well as by proteolytic degradation. Ubiquitin dependence of p21 
degradation is an unresolved issue. A lysine-less variant of p21 was unstable 
showing that its degradation does not completely rely on ubiquitylation (Sheaff et al., 
2000). However, another group later showed that p21 was polyubiquitylated at its N-
terminal methionine which might be sufficient for its degradation (Bloom et al., 2003). 
In short, it is still not clearly established how p21 is targeted to the proteasome.  
p21 is a globally loosely folded protein lacking a proper secondary or tertiary 
structure which makes it a suitable candidate for ubiquitin-independent degradation 
pathway (Richard W. Kriwacki 1997). There is no known homologue of p21 in yeast. 
However, it is interesting to study if the loosely folded structure of p21 would enable 
its ubiquitin-independent degradation in yeast. Also, it would be a useful substrate for 
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comparative studies with ODC to elucidate common mechanisms underlying 
ubiquitin-independent proteolytic pathway.   
Therefore, I studied the degradation of human p21 (hp21) in yeast. hp21 tagged at its 
C terminus with 2xHa was expressed under the CuSO4 inducible cup promoter. The 
steady state levels of hp21 in a WT strain was compared with the proteasome mutant 
pre1-1 and the ubiquitin-activating enzyme (E1) mutant uba1-ts26 at 30oC after 
induction with CuSO4. The total protein isolated was fractionated into pellet and 
supernatant fractions. p21 was non-detectable in all fractions of the WT strain (Fig. 
18A; lanes 1-3) whereas in the pre1-1 mutant, p21 was detected both in the pellet 
and the supernatant  (Fig. 18A; lanes 4-6). Interestingly, in the uba1-ts26 mutant p21 
accumulated mainly in the pellet fraction (Fig. 18A; lanes 7-9). This indicates that the 
degradation of hp21 occurs via the ubiquitin-dependent as well as -independent 
modes in yeast. The soluble p21 is degraded via the ubiquitin-independent route 
whereas the insoluble fractions are most likely taken care of by the quality control 
pathway which is ubiquitin-dependent.  
The results described above establish that p21 is rapidly degraded in yeast. 
Therefore, it is interesting to ask whether p21 competes with ODC for degradation. 
To answer this question, the steady state levels of ODC were studied upon hp21 
overexpression. The CuSO4 inducible hp21-2xHa was co-expressed with ODC-2xHa 
expressed under the ODC promoter. ODC-2xHa co-expressed with the vector 
plasmid served as the control. In a WT strain, no stabilization of ODC was seen when 
hp21 was overexpressed (Fig18B, right panel). Consequently, the experiment was 
repeated in the ump1-Δ mutant which lacks the proteasome maturation factor Ump1 
and therefore has reduced amounts of functional proteasomes (Ramos et al., 1998). 
Steady state levels of ODC were higher when p21 was overexpressed (Fig18B, left 
panel). It is however interesting to note that steady state levels of ODC were 
unaffected in the ump1-Δ mutant compared to wild-type (Gödderz, 2010). Therefore, 
when the proteasome activity is compromised, a competition of ODC with hp21 for 
degradation in yeast can be demonstrated.  
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Fig. 18: Ubiquitin-independent proteasomal degrdation of human p21 in yeast and its 
competition with ODC for degradation. (A) Western blot analysis after SDS-PAGE showing steady 
state levels of human p21 in pre1-1 and uba1-ts26 mutant strains compared to wild-type. The 
expression of hp21 was induced with 100 µM CuSO4. After glass-bead lysis of the pelleted yeast 
cells, the total lysate (T) was centrifuged at 30000xg for 30 min to separate the supernatant (S) and 
pellet (P) fractions. (B) Western blot analysis after SDS-PAGE comparing steady state levels of ODC 
with or without co-expression of h21 and grown in the presence or absence of 100 µM CuSO4 as 
indicated. This comparison was done in WT and ump1-Δ strains. The graph shows the results of a 
quantification of ODC-2xHa signals normalized to the Tpi loading control. Levels are given relative to 
the respective levels of ODC-2xHa in cells grown without 100 µM CuSO4 and co-expression of hp21, 
which was set to 1. Error bars, s.d.; n = 2. 
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4.2.5. Specificity of Rpt4 and Rpt5 Ar-Φ loop in substrate engagement and 
targeting of ODC 
The experiments detailed above have demonstrated that ODS mediates proteasomal 
binding of ODC/Oaz1 heterodimer to the 26S proteasome and that it binds most 
likely to the base subcomplex as the lid was dispensable for ODC degradation.  The 
base subcomplex consists of the hexameric Rpt1-6 ATPase ring as well as the Rpn1 
and Rpn2 subunits. Axially positioned aromatic-aliphatic (Ar-Φ) loops of the six 
ATPases are thought to make contact to unstructured domains in substrates 
engaging them for proteasomal targeting (Zhang et al., 2009). Erales et al. showed 
that the six different ATPases have asymmetric functions. They individually mutated 
conserved tyrosine residues to alanine (Y-A) in the Ar-Φ loop of each of the six Rpt 
subunits and showed by analysing the resulting strains that the Ar-Φ loops of the Rpt 
subunits are functionally different. Interestingly, they also showed that mouse ODC is 
specifically stabilized when expressed in yeast rpt4 and rpt5 Y-A loop mutants 
(Erales et al., 2012). Therefore, I asked whether the same is true for yeast ODC. 
Analysis of the steady-state levels of ODC revealed that yeast ODC is also 
specifically stabilized in rpt4 and rpt5 mutants (Fig. 19A). This observation prompted 
me to ask whether Rpt4 and Rpt5 loops are the most important for the degradation of 
all proteasomal substrates. Therefore, steady state levels of few other ubiquitin-
independent and ubiquitin-dependent substrates were checked in these mutants. The 
artificial ubiquitin-independent fusion substrate ODS-Ura3 (Godderz et al., 2011) was 
not stabilized in any of the rpt mutants (Fig. 19B). Similar was the case with hp21. 
However, hp21 is a rapidly degraded protein and therefore its levels are hard to 
detect in wild-type cells as shown in Fig 18A. No p21 could be detected by western 
blot in any of the rpt mutants indicating that their degradation is not impaired in these 
mutants (data not shown). I then analysed the steady state levels of three different 
ubiquitin-dependent substrates, namely, yeast antizyme (Palanimurugan et al., 
2004), an N-end rule substrate (Ub-R-eK-Ha-Ura3) and a Ubiquitin Fusion 
Degradation (UFD) pathway substrate (Ub-V76-eK-Ha-Ura3)(Ghislain et al., 1996; 
Varshavsky, 1996). Unlike ODC, no specific preferences for any of the Rpt subunits 
were observed (Fig. 20A-C).  
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Fig. 19: ODC is stabilized in rpt4 and rpt5 loop mutants. (A) Western blot analysis after SDS-
PAGE showing steady state levels of ODC-2xHa in rptY-A loop mutants compared to wild-type. The 
growth media were supplemented with 100 µM spermidine to induce ODC degradation. (B) Western 
blot analysis after SDS-PAGE showing steady state levels of ODS-Ura3 in rptY-A loop mutants 
compared to wild-type. The graphs show the results of a quantification of the corresponding Ha 
signals normalized to the Cdc11 loading control. Levels are given relative to WT, which was set to 1. 
Error bars, s.d.; for A, n =4 and for B, n =3.  
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Fig. 20: Ubiquitin-dependent substrates are not strongly stabilized in rpt4 and rpt5 loop 
mutants. (A) Western blot analysis after SDS-PAGE showing steady state levels of Ub-R-eK-Ha-
Ura3 in rptY-A loop mutants compared to wild-type. Protein expression was induced with 100 µM 
CuSO4. Western blot was done with anti-Ha antibody. (B) Same as in (A) but with Ub-V76-eK-Ha-
Ura3 as a substrate. (C) Same as in (A) and (B) with 2xMyc-Oaz1 as a substrate. Anti-Myc antibody 
was used for western blot analysis. The graphs show the results of a quantification of the 
corresponding Ha or Myc signals normalized to the Cdc11 or Tpi loading controls. Levels are given 
relative to WT, which was set to 1. Error bars, s.d.; for A, n =3, for B, n =3 and for C, n=2.   
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4.3. Characterization of the role of antizyme in ODC targeting 
The established role of antizyme in ODC degradation is the formation of a 
heterodimer with ODC and inducing a conformational change thereby exposing the 
ODC degradation signal (Godderz et al., 2011; Li and Coffino, 1993). However, it has 
been hypothesised that antizyme may play a further role in ODC degradation. Li and 
Coffino showed that an N-terminal half of antizyme is necessary for ODC degradation 
although it is the C-terminal half of antizyme that mediates the exposition of the 
degradation signal (Li and Coffino, 1994). Using spacer sequence insertions between 
ODS and the rest of ODC, Gödderz et al. showed that exposure of ODS alone can 
trigger Oaz1-independent degradation of ODC in yeast. Interestingly the presence of 
antizyme further destabilized these ODC variants (Godderz et al., 2011). These 
observations point to the possibility that antizyme does something more than 
exposition of ODS. In this section, I explored this hypothesis using an array of 
antizyme fusion constructs.  
4.3.1. ODS fused to stable antizyme is degraded in a ubiquitin-independent 
manner 
In addition to the unstructured domain, antizyme might provide a binding site to the 
proteasome to mediate ubiquitin-independent ODC degradation. Therefore, a stable 
version of antizyme (Oaz1-4res) (Fig. 21B) was used to make antizyme fusion 
constructs to check whether antizyme could target otherwise stable proteins like Ura3 
to the proteasome. Four different constructs were made as shown in Fig. 20A. 
Cycloheximide chase analysis of these constructs revealed that the antizyme fusion 
to Ura3 does not change the stability of the protein [Fig. 21C; (Stadelmayer, 2014)]. 
Interestingly however, the ODS-Oaz1-4res fusion protein was unstable (Fig. 21D) as 
was the ODS-Oaz1-4res-Ura3 fusion (Fig. 21E). It was therefore imperative to ask if 
this observed degradation is ubiquitin-independent or not and whether it is mediated 
by the proteasome. This was indeed the case. As observed earlier for ODC, both 
ODS-Oaz1-4res and ODS-Oaz1-4res-Ura3 were degraded faster in a uba1-ts26 
mutant (Fig. 22A and C). This indicates that these substrates compete with ubiquitin-
independent substrates at the proteasome. Addition of the proteasome inhibitor 
MG132 partially stabilized both fusion proteins showing that they are indeed 
degraded in a ubiquitin-independent manner by the proteasome (Fig. 22B and D).  
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Fig. 21: Stability of various antizyme fusion constructs. (A) Schematic representation of the 
various antizyme-4res fusion constructs. (B) Cycloheximide chase experiments showing that Oaz1-
4res-2xHa is a stable protein in yeast. (C) Same as in (B) but with the construct Oaz1-4res-Ura3-
2xHa. (D) Cycloheximide chase experiments showing that ODS-Oaz1-4res-2xHa is rapidly degraded 
in yeast. (E) Same as in (D) but with the construct ODS-Oaz1-4res-Ura3-2xHa. All western blot 
analyses were done with anti-Ha antibody. Cdc11 served as loading control. The graphs show the 
results of a quantification of the corresponding Ha signals normalized to Cdc11. Levels are given 
relative to the protein levels at 0 time point which was set to 100%. Error bars, s.d.; for D, n =3, and 
for E, n =2  
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Fig. 22: Ubiquitin-independent proteasomal degradation of antizyme fusion constructs. (A) 
Cycloheximide chase experiment showing that ODS-Oaz1-4res-2xHa is degraded faster in a uba1-
ts26 mutant compared to wild-type. The graph shows the results of a quantification of the 
corresponding Ha signals normalized to Cdc11. (B) Steady state levels of ODS-Oaz1-4res-2xHa in a 
pdr5-Δ strain with and without proteasome inhibition with 20 µM MG132 for 1 hour. (C) Steady state 
levels of ODS-Oaz1-4res-Ura3-2xHa in a uba1-ts26 strain compared to wild-type. (D) Same as in (B) 
but with the construct ODS-Oaz1-4res-Ura3-2xHa. All western blot analyses were done with anti-Ha 
antibody. Cdc11 served as loading control. The graphs show the results of a quantification of the 
corresponding Ha signals normalized to Cdc11. Levels are given relative to either the protein levels in 
a wild-type strain or in the control yeast cells without proteasome inhibition which were set to 1. Error 
bars, s.d.; for A, B, D n =3, and for C, n =4.  
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4.3.2. Antizyme might have a binding site on the proteasome 
Gödderz et al. showed that the fusion of ODS to certain stable proteins like Ura3 can 
convert them to ubiquitin-independent proteasomal substrates. However, the ODS-
Ura3 fusion protein is not degraded as efficiently as ODC in yeast cells. There might 
be several reasons for its higher stability. One hypothesis is that ODS alone is not 
sufficient to effectively target proteins to the proteasome. Therefore, I asked if fusing 
ODS-Ura3 to stable antizyme renders it more unstable.  A growth assay was 
performed and the growth of wild-type yeast harbouring one of these constructs was 
scored on minimal media lacking uracil. The observed phenotypes indicate that ODS-
Oaz1-4res-Ura3 is less stable than ODS-Ura3 or Ura3 (Fig. 23A). This suggests that 
the presence of both ODS and antizyme enhances the degradation of the Ura3 
fusion protein indicated that antizyme helps substrate binding to the proteasome. As 
in the case of ODC, ODS-Oaz1-4res-Ura3 is stabilized in rpt4Y-A and rpt5Y-A loop 
mutants (Fig. 23B). This is a strong indication that both ODC and this fusion 
substrate have similar mechanisms of proteasomal targeting.  
  Results 
 
64 
 
 
Fig. 23: Antizyme fusion reduces the stability of ODS-Ura3. (A) Growth assay showing  the 
phenotype of a wild-type strain transformed with plasmids encoding Ura3-2xHa, ODS-Ura3-2xHa, and 
ODS-Oaz1-4res-Ura3-2xHa in minimal medium lacking LEU (left) or LEU-URA (right). (B) Growth 
assay showing the phenotypes of the various rptY-A loop mutants compared to wild-type transformed 
with the plasmid ODS-Oaz1-4res-Ura3-2xHa in minimal medium lacking LEU (top) or LEU-URA 
(bottom). 
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4.3.3. A genetic screen for the isolation of ODC stabilizing mutants 
Gödderz had previously performed a genetic screen for the isolation of mutants 
impaired in ODC degradation (Gödderz, 2010). A similar screen was setup aimed 
mainly at the identification of factors involved in ODC targeting in particular the 
binding sites of ODS and antizyme in the proteasome. As shown in Fig. 24, the 
parent strain harboured a genomic fusion of ODC encoding sequence to the 
auxotrophic marker LEU2 inserted into the LEU2 locus, a plasmid with the ubiquitin-
independent proteasomal substrate ODS-Oaz1-4res-Ura3-2xHa described in 
sections above, and a plasmid expressing the ubiquitin-dependent substrate R-β-gal 
from the PGAL1 promoter. The mutants were selected on minimal media plates lacking 
histidine and tryptophan (for the section of the plasmids) and either leucine or uracil 
or both (for selection of mutants that stabilized the reporter proteins). Mutants which 
are both Leu+ and Ura+ and not stabilizing the R-β-gal protein are the most desired 
ones as they would most likely be specifically affected in ODC targeting.  
The mutants isolated were subjected to various phenotypic analyses as shown in 
table 1. The dominant or recessive nature of the mutants was analysed by scoring 
the Leu and Ura phenotype upon crossing to a wild-type strain of the opposite mating 
type. Out of the several mutants picked from various plates, very few were both Leu+ 
and Ura+. Most of the mutants were recessive. Mutants 29, 31 and 61 were the most 
interesting as they were both Leu+ and Ura+ and did not affect the degradation of the 
R-β-gal protein. Further analysis includes grouping of these mutants into phenotypic 
classes and mapping their genomic positions. Mapping can be done either using the 
classical genetic complementation analyses or by whole genome sequencing.  
 
Fig. 24: The setup of the spontaneous mutant screen for the isolation of ODC stabilizing 
mutants 
Leu +/ Ura + / Leu + Ura +
Parent 
Mutant
ODC-ek-Ha-Leu2
ODS-Oaz1-4res-Ura3-2xHa
R-β-gal
Leu - / Ura -
Mutant selection
Desired mutants:  
26S proteasome subunits 
involved in ODC targeting  
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Table1: Phenotypic analysis of isolated mutants 
Mutant No. 
Selection 
plate 
Leu Ura 
YPD 
37⁰C 
SD 
37⁰C 
β-Gal 
Dominant/ 
Recessive 
1 Ura ̶ +++ +++ +++ ̶ Dom 
6 Ura ̶ + + + ++ Res 
9 Leu +++ ̶ +++ +++ ̶ Res 
16 Ura ̶ + + + white Res 
27 Leu ++ + +++ + +++ Res 
29 Leu +++ + +++ +++ ̶ Res 
31 Leu +++ + +++ +++ ̶ Res 
36 Leu ++ ̶ +++ +++ ̶ Res 
37 Ura ̶ (+) + + + Res 
38 Ura ̶ ++ +++ +++ ̶ Res 
39 Ura ̶ +++ +++ +++ ̶ Res 
42 Ura ̶ (+) + + ̶ Res 
44 Ura ̶ + ++ + (+) Res 
45 Ura (+) (+) + + + Res 
49 Ura ̶ ++ + + ̶ Res 
61 Leu +++ + +++ +++ ̶ Res 
64 Leu ++ ++ +++ +++ + Res 
 ̶    indicated same as WT and + indicates positive deviation from WT 
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4.4. Ubiquitin-dependent degradation of ODC  
ODC is one of the few ubiquitin-independent substrates of the proteasome that is 
thought to be degraded solely in a ubiquitin-independent manner. Recent data from 
our lab, however, suggested that this may not be the case. ODC, when expressed 
under the CuSO4-inducible PCUP1 promoter was degraded in an ubiquitin-dependent 
manner by the proteasome (Gödderz, D, unpublished data). Gödderz observed 
increased ODC levels in the proteasome mutant pre1-1 as well as in the E1 mutant 
uba1-ts26 compared to wild-type, suggesting that ODC under these conditions is 
degraded in a ubiquitin-dependent manner by the proteasome. In this chapter, I 
reproduced this observation and further explored the factors involved in ubiquitin-
dependent ODC degradation.  
4.4.1. ODC is degraded by the proteasome in a ubiquitin-dependent manner 
upon overexpression 
Previous data from our lab showed that ODC-GFP when overexpressed along with 
antizyme, formed cellular aggregates upon proteasomal inhibition (Gödderz, 2010). 
Also when human p21 was expressed from the PCUP1 promoter, the ubiquitin-
dependent fraction was mainly seen in the pellet showing that aggregated p21 is 
ubiquitylated and degraded by the proteasome (Fig. 18A). It could therefore be 
possible that ubiquitin-dependent ODC degrdation is simply a result of its 
aggregation. To rule out this possibility, I checked whether ODC formed aggregates 
upon its overexpression along with antizyme. Both ODC and Oaz1 were expressed 
from the PCUP1 promoter and their steady state levels were analysed with and without 
CuSO4 addition. The cell lysates were subjected to ultracentrifugation (100000xg) for 
30 minutes and the fractions were separated by SDS-PAGE before western blot 
analysis (Fig. 25). As observed previously by Gödderz, a clear stablization of ODC 
was seen both with (Fig. 25A) and without (Fig. 25B) CuSO4 induction in pre1-1 and 
uba1-ts26 mutants. In both cases, ODC accumulated mainly in the soluble fraction. 
Interestingly however, Oaz1 upon its overexpression was distributed between 
supernanat (S) and pellet (P) fractions. This is a good indication that Oaz1 is more 
aggregation-prone than ODC.  
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Fig. 25: Ubiquitin-dependent ODC degradation. (A) Western blot analysis after SDS-PAGE 
showing steady state levels of ODC and Oaz1 in pre1-1 and uba1-ts26  mutant strains compared to 
wild-type. After glass-bead lysis of the pelleted yeast cells, the total lysate (T) was centrifuged at high 
speed to separate the supernatant (S) and pellet (P) fractions. Tpi served as loading control. (B) 
Same as (A), except that the expression of both ODC and Oaz1 was induced with 100 µM CuSO4. 
4.4.2. Ubiquitin-dependent ODC degradation is independent of its 
unstructured domain 
The requirement of the N-terminal unstructured domain (ODS) for ubiquitin-
independent ODC degradation was discussed in detail in section 4.2.1. Therefore, an 
obvious question to ask was whether ODS is relevant for ubiquitin-dependent ODC 
degradation. Additionally, to rule out any influence of the 2xHa tag on ubiquitin-
dependent ODC degradation, ODC and its variant without ODS (ΔODS-ODC) were 
constructed without any epitope. A rabbit polyclonal antibody against yeast ODC was 
used for western blot analysis. ODC and ΔODS-ODC were expressed from the PCUP1 
promoter and their steady state levels were analysed in wild-type, pre1-1 and uba1-
ts26 strains upon induction with CuSO4. ODC was stabilized in pre1-1 and uba1-ts26 
mutants compared to wild-type as previously observed, showing that the tag did not 
have any influence on this phenotype (Fig. 26A; lanes 1-3). Surprisingly, ΔODS-ODC 
was also stabilized in pre1-1 and uba1-ts26 mutants showing that ODS is not 
required for ubiquitin-dependent degradation of ODC (Fig. 26A; lanes 4-6).  
T       S      P   T      S      P    T  S P             
WT                pre1-1         uba1-ts26
A
T       S      P  T      S      P T     S      P             
WT                pre1-1         uba1-ts26
B 100 µM CuSO4
Tpi
ODC-2xHa
2xMyc-Oaz1
Tpi
ODC-2xHa
2xMyc-Oaz1
̶   CuSO4
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I then asked whether the ubiquitin-dependent degradation of ODC requires 
polyamines. Steady state levels of ΔODS-ODC-2Xha were compared in a wild-type 
strain with and without spermidine. The ΔODS variant of ODC was used to rule out 
the influence of the ubiquitin-independent degradation pathway. No differences in 
steady state levels were seen showing that this mechanism does not depend on 
polyamines (Fig. 26B). Figure 26C shows the steady state levels of DHFR-2xHa, a 
stable protein. This experiment was done as a control to rule out any general 
influence of the PCUP1 promoter in pre1-1 and uba1-ts26 mutants. The levels do not 
change significantly in pre1-1 and uba1-ts26 upon induction with CuSO4 showing that 
the observed effect is specific for ODC.  
 
Fig. 26: Ubiquitin-dependent ODC degradation is ODS-independent. (A) Western blot analysis 
after SDS-PAGE showing steady state levels of ODC and ΔODS-ODC expressed from PCUP1 
promoter in pre1-1 and uba1-ts26 mutant strains compared to wild-type. Expression was induced with 
100 µM CuSO4. Western blot was done with anti-ODC polyclonal antibody. The specificity of the 
antibody is demonstrated by the lack of the specific band in a control with the vector plasmid (last 
lane). The faint band corresponds to wild-type ODC expressed from the genomic locus. (B)  Western 
blot analysis after SDS-PAGE showing steady state levels of ΔODS-ODC-2xHa in a wild-type strain 
with a without 100 µM spermidine. Expression was induced with 100 µM CuSO4. (C)  Same as (A), 
with DHFR-2xHa as substrate. For both (B) and (C), western blots were done with anti-Ha antibody. 
Pgk and Tpi served as loading controls. 
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4.4.3. Ubiquitin-dependent ODC degradation is independent of antizyme  
The ΔODS-ODC construct is particularly useful for studying the ubiquitin-dependent 
degradation of ODC as it is degraded solely by this mechanism. In this construct, any 
influence from the canonical ubiquitin-independent degradation pathway can be 
eliminated. Therefore it was used to check if ubiquitin-dependent ODC degradation is 
antizyme-dependent or not. ΔODS-ODC expressed from the PCUP1 promoter was 
introduced into wild-type, oaz1-Δ and OAZOE (overexpression of the in frame version 
of antizyme) strains and its steady state levels were analysed. Both CuSO4-induced 
and non-induced states were analysed. In the non-induced state, ΔODS-ODC could 
not be detected very well in this particular blot. As expected, wild-type ODC encoded 
by the genomic locus was stabilized in the oaz1-Δ mutant whereas it disappeared in 
the OAZOE strain (Fig. 27A). Surprisingly, upon CuSO4 induction, there was no 
difference in the levels of ΔODS-ODC between the tested conditions. This shows that 
ubiquitin-dependent degradation of ODC is antizyme-independent.  
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Fig. 27: Antizyme-independent degradation of ODC (A) Western blot analysis after SDS-PAGE 
showing steady state levels of ΔODS-ODC expressed from PCUP1 promoter in wild-type strain 
compared to oaz1-Δ and OAZ1
OE
. Western blot was done with anti-ODC polyclonal antibody. The 
numbers 1, 2 and 3 corresponds to the three different yeast transformants used for the experiment. 
Pgk served as loading control. (B) Same as (A) except that protein expression was induced with 100 
µM CuSO4.  
4.4.4. Protein quality control pathway might not influence ubiquitin-dependent 
ODC degradation 
The Protein Quality Control pathway (PQC) takes care of detrimental misfolded 
proteins by refolding, degradation or sequestering them in specific cellular 
compartments (Chen et al., 2011). Molecular chaperones like Hsp70 play a vital role 
in these processes. Molecular chaperones have been shown to be involved not only 
in the folding and refolding of polypeptides but also in their proteasomal degradation. 
(Arndt et al., 2007) The chaperone Hsp70 has been shown to stimulate 
polyubiquitylation of dentaured substrates via the ubiquitin ligases Ubr1 and Ubr2. 
(Nillegoda et al., 2010) Therefore, a mutant deficient in the Ssa class of Hsp70 
proteins (ssa1-45) was used to see if the ubiquitin-dependent degradation of ODC 
occurs via the PQC pathway (Becker et al., 1996).  
100 µM CuSO4
̶   CuSO4
1      2      3      1    2  3       1   2    3
WT                oaz1-Δ OAZ1OE
1       2      3      1    2  3       1   2    3
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B
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Full length ODC-2xHa expressed from the PCUP1 promoter was introduced into WT 
and ssa1-45 mutant strains. Whole cell lysates were analysed by SDS-PAGE 
followed by western blotting. Upon induction with CuSO4, ODC-2xHa levels were 
significantly reduced (Fig. 28B). At this point, the reason for this reduction is not 
clear.  Therefore, the blot was reprobed with antibodies against the proteasome (anti-
Rpt5) and the chaperone Hsp90. There were no visible differences between the 
levels of Rpt5 . However, a slight increase in Hsp90 levels were observed in ssa1-45 
mutants. When the experiment was repeated with ΔODS-ODC-2xHa, upon induction 
with CuSO4, the protein levels remained the same in both strains (Fig. 28B). This 
shows that ubiquitin-dependent degradation of ODC is independnet of Hsp70 and 
therefore might not involve the PQC pathway.  
 
Fig. 28: Ubiquitin-dependent ODC degradation is not influenced by Hsp70. (A) Western blot 
analysis after SDS-PAGE showing steady state levels of ODC-2xHa expressed from PCUP1 promoter 
in wild-type strain compared to ssa1-45 mutant with and without induction with CuSO4. Western blot 
was done with anti-Ha antibody. The blot was later reprobed with antibodies against Rpt5 and Hsp90. 
Tpi served as loading control. (B) Same as (A), except that ΔODS-ODC-2xHa was used.  
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5. Discussion 
5.1. Role of polyamines in feedback regulation of ODC 
Polyamines are multivalent cellular polycations whose levels are controlled by a 
feedback mechanism which involves the regulation of its biosynthetic enzyme ODC. 
This feedback regulation involving ODC and its regulatory protein antizyme is 
conserved from yeast to humans (Palanimurugan et al., 2014). As described in the 
introduction, various enzymes involved in this pathway including ODC are therapeutic 
targets for cancer and other diseases. In this thesis, yeast was used as a model 
organism to decipher some of the details of this complex mechanism. Discussed 
below are some observations and findings that add to this regulatory network. 
5.1.1. An additional role of polyamines in ODC degradation 
The canonical regulation of ODC by polyamines occurs via up-regulation of the ODC 
regulatory protein antizyme. The levels of antizyme are strictly regulated by 
polyamines via two independent mechanisms (Palanimurugan et al., 2014). Firstly, 
polyamines promote antizyme translation by a mechanism that involves ribosomal 
frameshifting to bypass an internal stop codon (Matsufuji et al., 1995). Our laboratory 
has recently elucidated the mechanism of how polyamines regulate translational 
decoding of antizyme mRNA in yeast cells. Co-translational binding of polyamines to 
the nascent antizyme polypeptide promotes completion of antizyme synthesis. At low 
concentrations of polyamines, the nascent antizyme polypeptide causes a stalling of 
ribosomes, a process that initially requires a low ribosome density that is caused by a 
pause at  the frameshifting site (Kurian et al., 2011). Secondly, polyamines inhibit the 
ubiquitin-dependent degradation of Oaz1, the mechanism of which remains to be 
elucidated (Palanimurugan et al., 2004). Complementing earlier in vivo data 
(Gödderz, 2010), a third mechanism of regulation of ODC by polyamines was 
characterized in the present work. The three modes of regulation of ODC by 
polyamine are depicted in Figure 29.    
Gödderz observed that ODC degradation was enhanced in vivo by spermidine in 
spite of comparable Oaz1 levels (Gödderz, 2010). Using an in vitro ODC degradation 
assay, I complemented her observation by showing that both spermidine and 
spermine directly enhanced ODC degradation (Fig. 9). Spermine showed a greater 
stimulatory effect than spermidine on in vitro degradation of ODC (Fig. 9). The 
reason for this in vitro effect is not yet clear. Spermine showed a higher binding 
affinity to antizyme in comparison to spermidine (Kurian et al., 2011). However, it is 
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not clear whether the binding of polyamines to antizyme mediates this enhanced 
degradation.  
In order to understand the specificity of this effect on ODC degradation, we tested 
whether polyamines augment general proteasome activity or the degradation of 
ubiquitin-dependent substrates. Polyamines slightly inhibited chymotrypsin-like 
activity of the proteasome in vitro, and had no effect on the degradation of ubiquitin-
dependent substrates in vivo (Fig.10). Since polyamines bind antizyme, polyamines 
might enhance ODC/Oaz1 heterodimer formation thereby enhancing ODC 
degradation. In co-pull down experiments, however, polyamines did not show any 
detectable effect on the binding of ODC to Oaz1 (Fig. 11). Nonetheless, it is still 
possible that this binding assay is not sensitive enough to capture physiologically 
relevant but small differences in binding affinity. Alternatively, binding of polyamines 
to the complex might either cause a conformational change in ODC resulting in a 
better exposure of the unstructured domain thereby enhancing degradation (Godderz 
et al., 2011) or that polyamine binding to Oaz1 increases its affinity to an additional 
binding site in the proteasome (Godderz et al., 2011; Li et al., 1996). Additional 
studies are required to resolve this issue. Structural analyses of the ODC/Oaz1 
complex bound to the 26S in the presence and absence of polyamines will be 
extremely valuable not only in determining the mechanism of this enhanced 
degradation but also in determining any additional binding interactions between 
ODC/Oaz1 and the proteasome.  
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Fig. 29: Modes of regulation of ODC by polyamines. Polyamines regulate ODC levels by (1) 
inducing antizyme translation by mediating +1 ribosomal frameshifting of its mRNA (2) inhibiting 
ubiquitin-dependent degradation of antizyme (3) enhancing ubiquitin-independent degradation of 
ODC 
5.1.2. Spermidine and spermine play similar roles in ODC regulation in yeast 
Gödderz observed that spermidine addition to the growth media had a much stronger 
effect on Oaz1 stabilization in wild-type yeast cells than addition of spermine 
(Gödderz, 2010). However, one cannot conclude that spermidine is the major in vivo 
player that mediates polyamine induced regulation of ODC via antizyme. This is 
because spermine is taken up less efficiently by yeast cells compared to spermidine 
(Erez and Kahana, 2001). Therefore the observed differences could merely stem 
from differences in the uptake of various polyamines. Also, in wild-type yeast cells, 
both spermine and spermidine can be interconverted to each other. To eliminate the 
interconversion of spermine to spermidine, I used the strain (spe4-∆) lacking the 
enzyme spermine synthase. Since there were no significant differences in ODC or 
Oaz1 levels detectable between wild-type and spe4-∆ cells (Fig. 12), we could 
conclude that formation of spermine from spermidine is not critical for ODC targeting 
in vivo, which does not exclude the possibility that spermine contributes to this 
regulation.  
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5.1.3. Role of acetylated polyamines in ODC degradation 
Polyamine acetylation is necessary for the catabolism and export of polyamines 
(Casero and Pegg, 1993). Therefore, acetylation is another way of regulating 
polyamine levels in the cell. In mammals acetylation is carried out by the highly 
regulated spermidine/spermine-N(1)-acetyltransferase (SSAT), whereas in yeast the 
enzyme polyamine acetyl transferase (Paa1) had been suggested as a key enzyme 
in polyamine acetylation (Liu et al., 2005; Pegg, 2008). In order to understand if there 
is any cross-talk between the two modes of polyamine regulation, the effects of 
acetyl-polyamines on ODC degradation and Oaz1 stabilization were analyzed. No 
significant effect could be seen under the tested conditions in the paa1-∆ mutant 
compared to wild-type (Fig. 13B). Besides, acetylation of spermidine clearly inhibited 
its binding to antizyme (Fig. 13A). This is most likely due to the neutralization of the 
positive charges on polyamines by the acetyl groups. These findings indicate that 
acetylation of polyamines does not play a role in promoting ODC degradation.  
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5.2. Ubiquitin-independent substrate targeting to the proteasome 
Most of the known proteasomal substrates depend on ubiquitin conjugation for 
recognition at the proteasome. In this thesis, I investigated the mechanism of 
degradation of certain substrates that does not require ubiquitin for their degradation. 
I asked whether such ubiquitin-independent substrates have some common features 
that make them susceptible to degradation. Some of these findings are discussed 
below. 
5.2.1. Factors involved in ODC/Oaz1 targeting to the proteasome 
Gödderz et al. showed that an N-terminal unstructured domain in ODC termed ODS 
(ODC Degradation Signal) is essential for the degradation of yeast ODC. They also 
showed that ODS is replaceable and need to be a minimum of 25-30 residues in 
length. By extension of ODS with spacer elements they further demonstrated that 
ODC can be degraded in yeast without antizyme binding. However, binding of 
antizyme improved the degradation of ODC indicating that antizyme has an 
additional function in ODC degradation (Godderz et al., 2011). These findings 
pointed to the fact that binding of ODC/Oaz1 complex to the proteasome is mediated 
by ODC but were consistent with the possibility that Oaz1 may contribute an 
additional binding site. In Fig 15, I showed by means of an in vitro binding assay that 
ODS mediates proteasomal binding of ODC/Oaz1 complex and that its presence is 
essential for ODC binding. Prakash et al. showed that an unstructured region in the 
substrate is required for efficient proteasomal degradation of ubiquitin-tagged 
substrates. In these substrates, however, the unstructured regions are necessary for 
the proteasome to initiate unfolding rather than mediating proteasome binding as the 
binding is done by the ubiquitin tag (Prakash et al., 2004). Therefore, the 
unstructured domains in ubiquitin-dependent substrates might be functionally 
different from ODS. It was also shown that as few as 20 amino acids can serve as 
initiation sites for efficient degradation of ubiquitin-dependent substrates (Prakash et 
al., 2004). In the case of ODC, a 20 amino acid degradation signal is not enough for 
efficient degradation. This comparison reveals that, these observed differences in 
function could arise from differences in the length of the unstructured domains 
present in these substrates. Therefore, a longer unstructured domain like ODS might 
mediate proteasomal binding as well as engage the ATPases for unfolding and 
translocation. 
Having established that ODS mediates proteasomal binding, the next step was to 
investigate the receptor(s) for ODC on the proteasome. Gödderz et al. showed that 
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the lid subcomplex of the proteasome is dispensable for the degradation of ODC in 
vivo. Using isolated 26S proteasomes lacking the lid subcomplex, I complemented 
the in vivo data showing that in vitro degradation of ODC is not affected in this mutant 
proteasome (Fig.16).  Zhang et al. had proposed that ODC might also be recognized 
by ubiquitin receptors at the proteasome (Zhang et al., 2003). However, Gödderz 
showed that ODC was degraded faster in mutants lacking one or a combination of 
ubiquitin receptors and shuttle factors. Extending these findings, I could show that 
ODC is degraded faster in a mutant lacking multiple ubiquitin receptors (Fig. 17). 
Together, these findings strongly suggest that ubiquitin-dependent and ODC follow 
different modes of proteasomal association.  
5.2.2. Human p21 is degraded by the yeast proteasome in a ubiquitin-
independent manner 
p21 is a key cell cycle regulator in mammals. There are conflicting evidences 
showing that p21 act both as a tumour suppressor and an oncogene (Starostina and 
Kipreos, 2012). p21 is regulated at multiple levels including the post-translational 
level. It is not firmly established whether p21 is degraded in a ubiquitin-dependent or 
-independent manner. Multiple pathways seem to regulate p21 at the post-
translational level (Jariel-Encontre et al., 2008). It is therefore interesting to ask 
whether p21 is degraded in yeast and if so, whether the degradation is ubiquitin-
dependent or not.  Interestingly, p21 was degraded by the yeast proteasome in a 
ubiquitin-dependent as well as -independent manner resembling the earlier 
observation made in mammalian cells (Fig. 18A). p21 is a loosely folded protein and 
therefore a fraction of it was prone to aggregation. This aggregated from of p21 was 
degraded in a ubiquitin-dependent manner most likely involving the protein quality 
control pathway. On the other hand, the soluble fraction of p21 was degraded in a 
ubiquitin-independent manner. These findings are based on the observation that p21 
mainly accumulated in the pellet fraction in a uba-ts26 mutant. Besides, upon co-
expression with ODC, p21 competed with ODC for degradation (Fig. 18B). This is an 
indication that p21 and ODC compete at the proteasome for degradation possibly at 
the level of proteasomal recognition.  
5.2.3. Rpt4 and Rpt5 Ar-Φ pore loops are involved in ODC recognition at the 
proteasome 
Lander et al. showed that in a substrate-free stage, the Rpt subunits within the 
ATPase ring are arranged in a spiral staircase (Lander et al., 2013). However, upon 
substrate binding, the ATPase ring rearranges itself to form a ring with uniform 
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interfaces, a widened central channel coaxially aligned with the 20S CP, and a spiral 
orientation of pore loops (Matyskiela et al., 2013). Furthermore, Beckwith et al. 
showed that the three Rpt subunits (Rpt6, Rpt3 and Rpt4), which are located at the 
top of the pre-engaged spiral staircase are more important than the other three Rpt 
subunits (Rpt5, Rpt1 and Rpt2) for substrate engagement (Beckwith et al., 2013). In 
contrast, using mutants of Rpt Ar-Φ pore loops, Erales et al. showed that Rpt4 and 
Rpt5 are more important than the other Rpts for the degradation of mouse ODC in 
yeast (Erales et al., 2012). Also, the pore loops are known to make contacts with the 
unstructured regions of the substrate (Zhang et al., 2009). Therefore, I asked 
whether there is any specificity for the Rpt subunits in yeast ODC degradation. As in 
the case of mouse ODC, yODC was specifically stabilized in rpt4 and rpt5 Ar-Φ pore 
loop mutants (Fig. 19A). On the other hand, ubiquitin-dependent substrates and the 
ubiquitin-independent substrate, ODS-Ura3 did not show any clear specificity for the 
Rpt4 and Rpt5 pore loops (Figs. 19-20). The effect seems to be specific for ODC and 
therefore is a strong indication that Rpt4 and Rpt5 might be the receptors for ODS at 
the proteasome (Fig. 30).  
                    
Fig. 30: Model for recognition of ODC at the proteasome. This model depicts the recognition of the 
unstructured domain of ODC (ODS) by the proteasomal ATPase ring. The Rpt4 (grey) and Rpt5 (red) 
are more prominent in the recognition of ODS. The rest of the Rpt subunits are coloured in blue.  
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5.3. Antizyme might provide an additional binding site to the proteasome 
The proteasome is a busy cellular machinery with several substrates competing with 
each other at the same time for degradation. Since ODC is a rapidly degraded 
protein, it might have more than one way to prolong its staying time at the 
proteasome. Therefore, elements other than ODS might be involved in proteasomal 
targeting of ODC. Both polyamines and antizyme influence the degradation of ODC 
and could therefore promote proteasomal binding as well. Antizyme has been 
hypothesised to provide a binding site to the proteasome. Zhang et al. compared the 
Kcat and Km values in an in vitro degradation assay of mouse ODC by rat 
proteasomes in the presence or absence of rat AZ1. The Kcat value was little affected 
by AZ1 (0.22 and 0.20 min-1, respectively, without or with AZ1) whereas the Km value 
reduced from 13 to 1.6 mM, consistent with the observed 8-fold stimulation of ODC 
degradation by AZ1 (Zhang et al., 2003). Based on these values, they suggested that 
AZ1 improves the association of ODC with the proteasome, not the rate of its 
processing. The same group had previously shown that N-terminal part of antizyme 
is necessary to induce degradation of ODC but not for the interaction with ODC (Li 
and Coffino, 1994). They further showed that this N-terminal fragment of antizyme 
can target heterologous proteins to the proteasome (Li et al., 1996). Previous 
experiments from our lab complemented these observations. The extension of ODS 
by spacer elements made ODC susceptible to proteasomal degradation independent 
of antizyme. But presence of antizyme improved the degradation of these ODC 
variants showing that it has an additional function (apart from its role in exposing the 
unstructured domain) (Godderz et al., 2011). I further dissected the additional role of 
antizyme using an array of antizyme fusion constructs. Using a phenotypic assay, I 
showed that fusion of the stable variant of antizyme (Oaz1-4res), decreased the 
stability of ODS-Ura3 (Fig. 23). ODS-Ura3 was previously shown to be degraded in a 
ubiquitin-independent manner by the 26S (Godderz et al., 2011). Antizyme fusion 
further destabilized this fusion protein. Together, the previous findings along with the 
results presented in this thesis, the mode of targeting of ODC to the 26S has become 
clearer. I hypothesise that there are two binding elements in the ODC-Oaz1 
heterodimer; ODS and antizyme. ODS most likely binds to the pore loops of Rpt4 
and Rpt5. Antizyme might provide an additional binding site. It is also clear that 
antizyme alone cannot mediate binding of the heterodimer to the proteasome 
because the ΔODS-ODC/Oaz1 heterodimer did not bind the 26S in the in vitro 
proteasome binding assay (Fig. 15). Therefore, ODS is most likely the primary 
binding element and antizyme might function as an additional factor enhancing 
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proteasomal association.  Further studies are required to prove this hypothesis. A 
screen for spontaneous mutants stabilizing both ODC and the artificial ubiquitin-
independent substrate, ODS-Oaz1-4res-Ura3 has been initiated as part of this work 
and is ongoing (Fig. 24). This screen is aimed at isolating mutants that are incapable 
of binding ODS or Oaz1. An initial phenotypic analysis of selected mutants has been 
completed (Table. 1). The next step is to classify and map the mutations to a 
particular gene. Mapping can be done using genetic methods like complementation 
analysis with a yeast gene library or by whole genome sequencing of selected 
mutants. Additionally, structural analyses of the ODC/Oaz1 complex bound to the 
26S proteasome would be helpful in determining the exact interactions between 
these complexes.  
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5.4. Ubiquitin-dependent ODC degradation 
Many of the known ubiquitin-independent substrates have two modes of degradation. 
Rpn4 is a classic example. ODC, on the other hand, has so far been known to be 
degraded solely in a ubiquitin-independent manner. Surprisingly, Gödderz observed 
that, when ODC is expressed from the PCUP1 promoter, it is in part degraded in a 
ubiquitin-dependent manner (personal communication). This observation was 
reproduced in Fig. 25. Upon copper induction, the levels of ODC are much higher 
compared to the levels obtained when the gene is expressed from its own promoter. 
Unlike in the case of ubiquitin-dependent p21 degradation in yeast, the ubiquitin-
dependent ODC degradation was not a consequence of an aggregation of the 
ODC/Oaz1 heterodimer. Additionally, in a mutant strain impaired in the function of 
cytosolic heat shock factor Hsp70, ODC was not stabilized under these experimental 
conditions (Fig. 28). Together, these observations indicate that the ubiquitin-
dependent ODC degradation is mainly occurring independent of the protein quality 
control pathway. Interestingly, ubiquitin-dependent ODC degradation was unaffected 
by the presence of ODS, antizyme, or polyamines (Figs. 26-27). This indicates that 
this regulatory mechanism is independent of the canonical negative feedback 
regulation of ODC by polyamines.  Together, the ubiquitin-independent ODC 
degradation is a result of increased levels of ODC in the cell. The following scenario 
could be envisioned. Once the ubiquitin-independent pathway of ODC regulation is 
overwhelmed by high ODC levels (as in the case of copper induction), the ubiquitin-
dependent pathway takes over (Fig. 31). The physiological relevance of such a 
pathway is yet to be discovered. Since ODC levels are abnormally elevated in cancer 
cells, we could imagine that such an additional regulation might be relevant. This is to 
the best of our knowledge, the first indication that under certain experimental 
conditions, ODC can be degraded in a ubiquitin-dependent manner. E2 and E3 
enzymes responsible for ubiquitylation are yet to be discovered. Systematic analyses 
of ODC levels in a collection of known E2 and E3 could reveal the players involved.  
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Fig. 31: The two modes of ODC degradation. Depicted above are the two modes of ODC 
degradation by the 26S proteasome. The part on the right side is the canonical ubiquitin-independent 
mode of ODC degradation. The left part shows the ubiquitin-dependent ODC degradation mode 
discussed in the section above.  
 
 
 
 
 
 
 
 
 
 
26S proteasome
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5.5. Conclusions and outlook 
Together, the results presented in this thesis provide some new insights into the 
mechanism of ubiquitin-independent degradation of ODC. A previously unknown 
mode of regulation of ODC by polyamines was established. The role of the 
unstructured domain of ODC in the binding of the ODC/Oaz1 heterodimer to the 
proteasome was demonstrated using an in vitro proteasome binding assay 
developed in this study. This binding assay can now be used in future studies to 
check the binding of putative substrates and interactors to the proteasome. I also 
showed that antizyme might play an additional role in ODC targeting most likely by 
improving the binding of ODC to the proteasome. Identification of the relevant binding 
sites on antizyme and the proteasome are challenging topics for future studies. 
Finally, a new mode of degradation of ODC by ubiquitin conjugation has been 
described. These findings and observations form a basis for future studies on the 
regulation of ODC which could lead to new therapies targeting the polyamine 
regulatory pathway.  
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